Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer

Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer Jincong Q. Freeman, Jori B. Sheade, Fangyuan Zhao, Olufunmilayo I. Olopade, and 2 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3909360/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 8 You are reading this latest preprint version Abstract Purpose Integrative medicine (IM) has received ASCO endorsement for managing cancer treatment-related side effects. Little is known about racial differences in familiarity, interest, and use of IM among breast cancer patients. Methods Breast cancer patients enrolled in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort were surveyed regarding familiarity, interest, and use of IM: acupuncture, massage, meditation, music therapy, and yoga. Familiarity and interest, measured by a 5-point Likert scale, was modeled using proportional odds. Use was self-reported, modeled using binary logistic regression. Results Of 1,300 respondents (71.4% White and 21.9% Black), Black patients were less likely than White patients to be familiar with acupuncture (aOR 0.60, 95% CI: 0.41-0.87). While there was no differences in interest in acupuncture between Black and White patients (aOR 1.12, 95% CI: 0.76-1.65), Black patients were more interested in massage (aOR 1.86, 95% CI: 1.25-2.77), meditation (aOR 2.03, 95% CI: 1.37-3.00), music therapy (aOR 2.68, 95% CI: 1.80-3.99) and yoga (aOR 2.10, 95% CI: 1.41-3.12). Black patients were less likely than White to have used acupuncture (aOR 0.49, 95% CI: 0.29-0.84); but there were no racial differences in use of massage (aOR 0.83, 95% CI: 0.53-1.30), meditation (aOR 0.82, 95% CI: 0.47-1.43), music therapy (aOR 1.65, 95% CI: 0.82-3.32) and yoga (aOR 0.67, 95% CI: 0.37-1.20). Conclusion Black patients expressed more interest in IM than their White counterparts; there were no racial differences in IM use, except lower acupuncture use among Black patients. A breast program focused on equity should provide access to these services for breast cancer patients. Integrative medicine racial disparities breast cancer ChiMEC Introduction Breast cancer is the most common cancer type, with more than 3.6 million people living with breast cancer in the United States (U.S.) [ 1 ]. Breast cancer and its treatment can be associated with numerous side effects and symptoms, from cancer pain to lymphedema to hot flashes, [ 2 ] that can negatively impact patients’ treatment adherence and quality of life [ 3 ]. Reduction of side effects and management of symptoms typically consists of further medications, which carry their own adverse effect profiles. In 2017, the Society for Integrative Oncology (SIO) performed a systemic review focusing on randomized controlled trials from 1990 through 2015 of the use of integrative medicine (IM) modalities during and after breast cancer treatment [ 4 ]. This resulted in a set of evidence-based practice guidelines on the use of IM in breast cancer, which was subsequently endorsed by the American Society of Clinical Oncology (ASCO) in 2018 [ 5 ]. IM modalities, including acupuncture, therapeutic massage, meditation therapy, music therapy, and yoga therapy all have received ASCO’s endorsement for the treatment or management of various side effects and symptoms, particularly: hot flashes, nausea, anxiety or stress reduction, depression or mood disorders, and improving quality of life [ 5 ]. A recent study has documented that more than 50.0% of cancer patients and their caregivers are familiar with acupuncture, yoga therapy, and meditation therapy [ 6 ]. Multiple previous studies have reported breast and gynecological cancer patients’ growing interest in and demand for IM, however, these studies included only White female patients [ 7 – 10 ]. Use of IM has increased in recent decades [ 11 – 13 ]. A survey conducted in breast cancer survivors found that more than 80.0% of the survivors had either used a complementary and alternative therapy or visited a therapist in the past [ 11 ]. Black race and lower socioeconomic status (SES) have historically been associated with lower prevalence of IM utilization among U.S. adults, according to a study using the 2002 National Health Interview Survey [ 12 ]. Therefore, IM services are generally marketed toward White populations and those with higher SES. However, little is known about familiarity, interest, and use of IM among Black or African American breast cancer patients and survivors. To date, the best study about racial differences in interest and use of IM comes from a 2017 study out of the University of Texas MD Anderson Cancer Center, which surveyed 165 cancer patients, 43% of which were Black or African Americans, at an urban community hospital about interest and use of complementary and alternative therapies [ 14 ]. The study found that 90.6% of the patients were interested in therapeutic massage, followed by 72.7% in meditation therapy, 69.8% in yoga therapy, and 49.7% in acupuncture [ 14 ]. However, most were unprofessionally guided use, and both past and current IM use were low. In this study, 13.8% of the Black patients had used yoga therapy as compared to 42.9% of Asian and 25.7% of White patients, with no significant differences among these racial groups based on a Pearson’s Chi-square test. Moreover, the study did not perform multivariable regression analyses due to the small sample size [ 14 ]. Prior studies are small and descriptive, with the majority of cancer patients and survivors being White. Additionally, there is paucity of data on racial differences in familiarity, interest, and use of IM specifically among breast cancer patients. To fill these gaps in the literature, we sought to assess racial differences in familiarity, interest, and use of five ASCO-endorsed IM modalities for breast cancer symptom management: acupuncture, therapeutic massage, meditation therapy, music therapy, and yoga therapy in a large cohort of patients with breast cancer having been treated at the University of Chicago Medicine. Methods Study design and study population We conducted a cross-sectional survey among breast cancer patients who were enrolled in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort (ChiMEC). Briefly, ChiMEC is a hospital-based study having been enrolling patients diagnosed with breast cancer since 1993. Detailed information of ChiMEC has been previously published [ 15 ]. Eligible participants were aged 18 years or older. From July to September 2021, a REDCap survey was sent to 2,788 ChiMEC participants who consented to be followed up for subsequent surveys. All patients provided their written informed consent prior to study participation. The University of Chicago Institutional Review Board reviewed and approved this study. Measures of key variables Familiarity was measured by asking participants how familiar they were with these types of IM, using a 5-point Likert scale including not familiar at all, not very familiar, neutral, familiar, and very familiar. Interest was measured by asking participants how interested they would be in these IM modalities if offered at the center, using a 5-point Likert scale including not interested at all, not very interested, neutral, interested, and very interested. We also assessed cancer treatment-related symptoms as facilitators by asking participants how interested they would be in any type of IM if it treated hot flashes, chemotherapy-induced neuropathy, nausea, joint pain, back or other pain, depression or mood change, fatigue or tiredness, and anxiety or stress reduction. Other facilitating factors for interest included recommendation from a provider, cost not being a barrier, being covered by health insurance, and price willing to pay out-of-pocket for a session. To measure use of IM, we asked patients to “Select all of the therapies that you have had or received in the past.” Response options for each item were yes and no. We also assessed major barriers to IM use, including cost/money, lack of access to services, lack of transportation to service-providing facilities, lack of time, lack of interest, unaware of benefits of these services, low confidence about the benefits on these services, and lack of trusted information on these services by asking what, in general, prevents participants from using any IM modality. Covariates Demographic and behavioral characteristics, including age, race/ethnicity (Asian, Black, Hispanic, and White), highest level of education (High school/GED or less, post high school, trade/technical school, or some college, Associate’s degree, Bachelor’s degree, and graduate or professional degree), marital status, annual household income, type of health insurance (Medicare, Medicaid, private, and other), and history of tobacco and alcohol consumption (never, current, and past), were collected from the survey. Clinical characteristics such as duration from diagnosis to survey, American Joint Committee on Cancer (AJCC) stage group, hormone receptor (HR) status (HR-positive/ human epidermal growth factor receptor 2 [HER2]-negative, HER2-positive, and triple negative breast cancer [TNBC]), and Charlson comorbidity index (CCI, i.e., 0, 1, and ≥ 2) was obtained through clinical chart abstraction. Statistical analysis We calculated means and standard deviations (SD) for continuous data and tabulated frequencies and percentages (%) for categorical data. Demographic, behavioral, and clinical characteristics between racial/ethnic groups were compared using Student’s t tests or ANOA for continuous variables and Pearson’s chi-square or Fisher’s exact tests for categorical variables. Of note, Asian and Hispanic patients were included in the descriptive analysis but were excluded in subsequent analyses due to small group sample size. Multivariable proportional odds were modeled for familiarity with and interest in different IM modalities. Multivariable binary logistic regression was modeled for self-report of having used these modalities in the past. All models were adjusted for age, highest level of education, marital status, annual household income, type of health insurance, CCI, HR status, and AJCC stage group. To assess racial differences in familiarity, interest, and use of IM modalities, we calculated adjusted odds ratios (aOR) and 95% confidence intervals (CI). The level of significance was set at 0.05. All statistical analyses were performed using SAS 9.4 (SAS Institute, Cary, NC). Results Patient characteristics We received 1,300 survey responses from ChiMEC participants. Of the total, 71.4% were White, followed by 21.9% Black, 3.3% Asian, and 3.3% Hispanic; 59.1% were aged 40-65 years; 39.3% obtained a graduate or professional degree; 69.6% were married; 74.8% had private insurance and 23.5% were on Medicaid/Medicare; 65.8% were HR-positive/HER2-negative; and 98.9% had stage 0-III disease (Table 1). Given low percentages of Asian and Hispanic respondents, they were excluded in the following analyses. The mean age of White respondents was 61.4 (SD=11.3) years, whereas Black respondents’ mean age was 62.6 (SD=12.3) years. Compared with White patients, Black patients had higher percentages of having obtained high school/GED or less education (16.7% vs. 8.1%), a lower annual household income of less than $50,000 (43.4% vs. 11.3%), been enrolled in Medicaid (16.3% vs. 1.5%) or Medicare (25.2% vs. 17.2%), and a CCI of ≥2 (10.8% vs. 5.7%). A higher percentage of Black patients had TNBC than White patients (28.7% vs. 14.4%) (Table 1). Familiarity with integrative medicine Overall, 59.8% of the patients were familiar or very familiar with therapeutic massage, followed by 47.7% acupuncture, 47.6% meditation therapy, 47.0% yoga therapy, and 35.4% music therapy. Compared with White patients, Black patients had a higher percentage of being familiar or very familiar with music therapy (44.2% vs. 32.7%). However, a higher percentage of White patients reported being familiar or very familiar with therapeutic massage (60.9% vs. 56.4%), acupuncture (49.9% vs. 40.5%), or yoga therapy (47.8% vs. 44.3%) than Black patients (Table 2). After adjusting for covariates, Black patients were less likely than their White counterparts to be familiar with acupuncture (aOR 0.60, 95% CI: 0.41-0.87). We did not observe differences between Black and White patients in familiarity with music therapy, meditation therapy, therapeutic, or yoga therapy (Table 3). Interest in integrative medicine and facilitators Overall, 62.9% of the patients reported being interested or very interested in therapeutic massage, followed by 49.4% yoga therapy, 47.1% meditation therapy, 43.9% acupuncture, and 40.4% music therapy. By race, Black patients had higher percentages of being interested or very interested in therapeutic massage (74.0% vs. 59.5%), yoga therapy (62.6% vs. 45.5%), meditation therapy (60.7% vs. 43.1%), music therapy (56.2% vs. 35.8%), or acupuncture (49.2% vs. 42.3%) than did White patients (Table 4). In the adjusted proportional odds model, Black patients were significantly more interested in the use of music therapy (aOR 2.68, 95% CI: 1.80-3.99), yoga therapy (aOR 2.10, 95% CI: 1.41-3.12), meditation therapy (aOR 2.03, 95% CI: 1.37-3.00), and therapeutic massage (aOR 1.86, 95% CI: 1.25-2.77) than their White counterparts. There was no differences in interest in acupuncture between the racial groups (Table 3). Participants reported being interested or very interested when asked for interest in any of the IM modalities to address specific symptoms: joint paints due to aromatase inhibitors (Black 71.6% vs. White 66.2%), back pain or other pain (Black 71.0% vs. White 65.9%), fatigue (Black 63.8% vs. White 64.0%), anxiety or stress reduction (Black 61.3% vs. White 63.25), depression or mood changes (Black 50.4% vs. White 52.5%), hot flashes (Black 49.2% vs. White 44.1%), chemotherapy-induced neuropathy (Black 43.2% vs. White 38.0%), and nausea (Black 32.0% vs. White 30.2%). However, there were no significant differences in symptoms as facilitators for interest in IM between the races (Table 5). Generally, Black respondents expressed more interest in IM modalities if they were recommended by their doctors or nurses and were covered by health insurance. Black respondents typically were less willing to pay more than $0-$19 out of pocket for a session of any IM services (Table 6). Use of integrative medicine and barriers Overall, 41.6% of the patients had used therapeutic massage, followed by 26.1% acupuncture, 19.0% yoga therapy, 18.5% meditation therapy, and only 7.7% music therapy. Higher percentages of White patients reported having used therapeutic massage (42.9% vs. 37.5%), acupuncture (29.5% vs. 14.7%), yoga therapy (20.8% vs. 13.0%), and meditation therapy (18.8% vs. 17.5%) than Black patients. However, Black patients had a higher percentage of prior use of music therapy than did White patients (11.2% vs. 6.6%) (Table 7). In the adjusted logistic regression model, there were no differences between Black and White patients in self-reported use of the IM modalities surveyed, with the exception of acupuncture as Black patients were less likely than their White counterparts to have used acupuncture (aOR 0.49, 95% CI: 0.29-0.84) (Table 3). When participants were asked about barriers to use of any IM modality, higher percentages of Black patients reported cost (55.1% vs. 31.4%), lack of awareness of benefits of IM services (35.8% vs. 23.9%), lack of access to services (24.6% vs. 19.4%), and lack of transportation to service-providing facilities (13.0% vs. 9.3%) than White patients. White patients had a higher percentage of lack of time as a barrier to use than their Black counterparts (32.2% vs. 19.3%). Of note, confidence in the benefits of IM was high in both races (White 91% vs. Black 90.5%) (Table 8). Discussion To our knowledge, this is of the first and the largest study to examine racial differences in familiarity, interest, and use of five ASCO-endorsed IM modalities and to assess specific symptom-related facilitating factors for interest in, and key barriers to use of, these modalities among U.S. patients with breast cancer. In this diverse cohort of patients with breast cancer, familiarity of IM modalities was prevalent among Black and White patients. However, higher proportions, ranging from 26.9% to 48.6%, of the patients across the racial groups were still not familiar with these modalities. Black patients were less familiar with acupuncture than their White counterparts, but there were no differences between them in familiarity with therapeutic massage, meditation therapy, music therapy, and yoga therapy. These findings are somewhat consistent with a recent study of familiarity and interest in IM among cancer patients and their caregivers that non-White patients are less familiar with therapeutic massage than White patients, while levels of familiarity with acupuncture, meditation therapy, music therapy, and yoga therapy are similar between White and non-White patients [6]. Our findings suggest that patient education on IM and its associated benefits may be needed among breast cancer patients and survivors in order to increase patients’ knowledge and awareness of IM. Future research may be needed to explore reasons related to level of familiarity and how the findings could help inform and tailor IM education campaigns and programs specifically toward breast cancer patients and survivors. We found that most patients across the two racial groups were interested in the use of IM modalities, and the percentages of interest of IM use also increased when the patients were asked if any of these modalities were treated for a particular symptom such as joint pains, back pain, fatigue, anxiety or stress reduction, hot flashes, and chemotherapy-induced neuropathy. Our finding in increased interest of IM use aligns with a published study that patients who experience back, joint, or other pain are more likely to use acupuncture and therapeutic massage, though racial differences were not assessed [16]. Further, Black patients were twice as likely as their White counterparts to have expressed interest in music therapy, yoga therapy, meditation therapy, and therapeutic massage, which is contrary to prior findings in the general population that conclude Black patients are less interested in IM services than White patients [12]. Breast cancer patients may have unique needs, as a population-based research has indicated that cancer patients and survivors are more likely than the general population to have discussed IM use with a provider and have used these modalities in the past 12 months [17]. Our result also contradicts a recent study finding that levels of interest in IM are similar between non-White and White patients [6]. However, this study sample was relatively small, probably lacking statistical power. In addition, it included patients with different cancer types and their caregivers, and thus, the findings may not be comparable to our cohort of breast cancer patients [6]. It is worth noting that approximately 21.6%-40.6% of the patients across the racial groups reported being not very interested or not interested at all in using these IM modalities, even when they were asked if these modalities addressed specific common cancer treatment-associated symptoms. It is also important to note that most patients expressed greater interest in IM use if recommended by their providers and were willing to pay no more than $19 out of pocket for a session. Our findings indicate that Black patients may be in greater need for IM and that both provision and coverage of these modalities should be integrated as part of standard cancer care and services at comprehensive cancer centers in the U.S. The percentages of past use of IM modalities were low among Black and White breast cancer patients; the majority of the patients, between 57.1% and 93.4%, had not used these modalities in the past. These results are in line with a previous study that both past and current use of acupuncture, meditation therapy, yoga therapy, and therapeutic massage were low, ranging from only 5.6% to 46.3% [14]. Compared with White patients, a higher proportion of Black patients reported cost, lack of access to services, unaware of the benefits of these services as major barriers to IM use. Less than 10.0% of both Black and White patients reported low confidence in the benefits of the five surveyed IM modalities. After adjusting for key demographic and clinical characteristics, Black patients in our cohort were significantly less likely than their White counterparts to have used acupuncture, while there were no differences between the racial groups in past use of therapeutic massage, meditation therapy, music therapy, or yoga therapy. Our finding is consistent with the previous study partially that use of yoga therapy was similar between Black and White patients, however, multivariable regression modeling was not performed due to the small sample size [14]. It is important to point out that we did not ask whether the patients had used these IM modalities before, during, and/or after their cancer therapies, which is worth doing in future research to evaluate whether there are racial and ethnic differences in IM utilization over time and how these differences would impact breast cancer patients’ treatment adherence and quality of life. Our findings also suggest that providers at cancer centers should be promoting these IM services as recommended by ASCO guidelines to all patients which, as shown, may be likely to increase interest in breast cancer patients and survivors Furthermore, Black patients with breast cancer more frequently report nonadherence to endocrine therapy than their White counterparts, with side effect profile being one of the main causes of discontinuation [18, 19]. Therefore, the use of IM modalities to reduce side effects from breast cancer treatment and to manage symptoms may lead to greater adherence to endocrine therapy in Black patients. As we have shown Black patients are just as interested, if not more interested, in IM as their White counterparts, and there are likely unmet needs of IM among breast cancer patients, we should ensure equity to access these services for all our breast cancer patients, regardless of race. Several limitations of this study need to be noted. First, the data collected through the survey were self-reported, which were subject to recall error or social desirability bias. However, we expect such bias to be minimal since our research staff had little interaction with the patients. Therefore, their responses were unlikely influenced. Second, because we did not ask the participants whether they had use these services before their cancer diagnoses, during, and/or after their cancer treatment, with an approximately 47.0% response rate, the percentages of use of these IM modalities may have been either overestimated or underestimated. Third, we were not able to assess unmeasured characteristics, e.g., cultural background/influence, employment status, patient-provider discussion of IM, which might affect or help better explain the observed racial differences in familiarity, interest, and past use of IM. Thus, additional cultural and behavioral factors should be taken into consideration in future research. Lastly, participants in the ChiMEC may not be representative of all U.S. patients with breast cancer or other patient populations, and therefore, limiting the generalizability of our study findings. Despite the above limitations, this study has several strengths. Our study is the largest to date examining racial differences in familiarity, interest, and use of the five ASCO-endorsed IM modalities among patients with breast cancer. Another strength of this study was the inclusion of a racially diverse cohort of patients with breast cancer and key clinical characteristics that previous research was not able to assess. In conclusion, both Black and White breast cancer patients were familiar with the five ASCO-endorsed IM modalities, but Black patients expressed greater interest in the use of these modalities. There were no racial differences in prior use of IM, except an increased use of acupuncture among White patients. However, Black patients reported more health care and services access-related barriers than did their White counterparts. Promoting benefits of IM among breast cancer patients and facilitating patient-provider discussion of IM use may be needed. Furthermore, breast programs focused on health equity should provide access to these services for all patients. Declarations Data availability The data analyzed during the current study are not publicly available due to the ethics for patient information but can be made available from the corresponding author on reasonable request. Acknowledgements We are grateful to the participants who are enrolled in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort. We thank the Iannessa family for their generous donation to support this study and our acupuncture program at the University of Chicago Medicine. Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by a donation from the Iannessa family, the National Cancer Institute (P20CA233307), Susan G. Komen® (TREND21675016), Breast Cancer Research Foundation (BCRF-23-071), and the National Institute on Aging under grant award T32AG000243. Its contents are solely the responsibility of the author(s) and do not necessarily represent the official views of the National Institute of Health/National Institute on Aging. Author Contributions J.Q.F.: Conceptualization, data analysis, creating statistical tables, writing the initial manuscript, and formatting and preparation of manuscript submission. J.B.S.: Conceptualization, design, survey development, research implementation, writing the initial manuscript, and formatting and preparation of manuscript submission. F.Z.: Conceptualization, design, survey development, research implementation, data collection and cleaning. O.I.O.: Conceptualization, design, research implementation. D.H.: Conceptualization, design, survey development, research implementation, and overall supervision. R.N.: Conceptualization, design, survey development, research implementation, and overall supervision. All authors contributed to interpretations of the findings, writing, review, and editing of the manuscript, and approval of the final manuscript. Ethnics declarations Conflict of interest J.Q.F., J.B.S., F.Z., and D.H. have no relevant financial or non-financial conflict of interests to disclose. R.N. disclosed advisory board involvement with and research funding from Arvinas, AstraZeneca, BeyondSpring, Celgene, FujiFilm, Genentech/Roche, Gilead, Infinity, iTeos, Merck, OBI Pharma, OncoSec, Pfizer, Relay Therapeutics, SeaGen, Sun Pharma, and Taiho. O.I.O. disclosed financial relationships with CancerIQ, 54gnene, HealthWell Solutions, Tempus; research funding from Ayala Pharmaceuticals, Cepheid, Color Genomics, Novartis, and Roche/Genentech. Ethnical approval This study was conducted in line with the principles of the Declaration of Helsinki. Ethnics approval was granted by the University of Chicago Institutional Review Board. Consent to participate Written informed consent was obtained from all patients prior to study enrollment and participation. Consent to publish Not applicable. References Cancer Stat Facts : Female Breast Cancer. National Institute of Health. Retrieved Feb 3 from https://seer.cancer.gov/statfacts/html/breast.html Side Effects of Cancer Treatment. National Cancer Institute. Retrieved Feb 3 from https://www.cancer.gov/about-cancer/treatment/side-effects Paraskevi T (2012) Quality of Life Outcomes in Patients with Breast Cancer. Oncol Rev 6(1):e2. https://doi:10.4081/oncol.2012.e2 Greenlee H, DuPont-Reyes MJ, Balneaves LG et al (2017) Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 67(3):194–232. https://doi:10.3322/caac.21397 Lyman GH, Greenlee H, Bohlke K et al (2018) Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol 36(25):2647–2655. https://doi.org/10.1200/JCO.2018.79.2721 Larbi OM, Jiang C, McLane B et al (2021) Interest and Willingness to Pay for Integrative Therapies of Patients With Cancer and Caregivers. JCO Oncol Pract 17(11):e1622–e1630. https://doi:10.1200/OP.20.00471 Grimm D, Mathes S, Woelber L et al (2021) Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany. Arch Gynecol Obstet 303(5):1315–1330. https://doi:10.1007/s00404-020-05880-0 Schuerger N, Klein E, Hapfelmeier A, Kiechle M, Brambs C, Paepke D (2019) Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients. Breast Care (Basel) 14(1):35–40. https://doi:10.1159/000492235 Hack CC, Fasching PA, Fehm T, de Waal J, Rezai M, Baier B et al (2017) Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study. Integr Cancer Ther 16(2):165–175. https://doi.org/10.1177/1534735416668575 Viscuse PV, Price K, Millstine D, Bhagra A, Bauer B, Ruddy KJ (2017) Integrative medicine in cancer survivors. Curr Opin Oncol 29(4):235–242. https://doi.org/10.1097/CCO.0000000000000376 Boon HS, Olatunde F, Zick SM (2007) Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7:4. https://doi.org/10.1186/1472-6874-7-4 Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11(1):42–49. https://pubmed.ncbi.nlm.nih.gov/15712765/ Cutshall SM, Cha SS, Ness SM, Stan DL, Christensen SA, Bhagra A et al (2015) Symptom burden and integrative medicine in cancer survivorship. Support Care Cancer 23(10):2989–2994. https://doi.org/10.1007/s00520-015-2666-0 Jones D, Cohen L, Rieber AG, Urbauer D, Fellman B, Fisch MJ, Nazario A (2018) Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications. Integr Cancer Ther 17(2):371–379. https://doi.org/10.1177/1534735417735892 Zhao F, Copley B, Niu Q, Liu F, Johnson JA, Sutton T et al (2021) Racial disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer Res Treat 185(3):841–849. https://doi:10.1007/s10549-020-05984-w Pang R, Wang S, Tian L, Lee MC, Do A, Cutshall SM et al (2015) Complementary and Integrative Medicine at Mayo Clinic. Am J Chin Med 43(8):1503–1513. http://doi:10.1142/S0192415X15500858 Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J (2011) Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv 5(1):8–17. https://doi:10.1007/s11764-010-0153-7 Spencer JC, Reeve BB, Troester MA, Wheeler SB (2020) Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors. Psychooncology 29(4):647–654. https://doi.org/10.1002/pon.5289 Wheeler SB, Spencer J, Pinheiro LC, Murphy CC, Earp JA, Carey L, Reeder-Hayes KE (2019) Endocrine Therapy Nonadherence and Discontinuation in Black and White Women. J Natl Cancer Inst 111(5):498–508. https://doi.org/10.1093/jnci/djy136 Tables Table 1. Demographic, behavioral, and clinical characteristics of breast cancer patients, overall and by race/ethnicity Characteristic Total (N=1,300), N (%) White (n=928), n (%) Black (n=285), n (%) Asian (n=43), n (%) Hispanic (n=43), n (%) p -value a Age b , mean (SD) 61.2 (11.7) 61.4 (11.3) 62.6 (12.3) 54.5 (12.5) 52.8 (11.1) <0.001 Age group b (year) 65 53 (4.1) 768 (59.1) 479 (36.9) 29 (3.1) 555 (59.8) 344 (37.1) 14 (4.9) 149 (52.3) 122 (42.58) 5 (11.6) 31 (72.1) 7 (16.3) 5 (11.6) 32 (74.4) 6 (14.0) <0.001 Highest level of education High school/GED or less Post high school, trade/technical school, or some college Associate’s degree Bachelor’s degree Graduate or professional degree 127 (10.2) 202 (16.2) 87 (7.0) 341 (27.3) 491 (39.3) 73 (8.1) 126 (14.0) 58 (6.5) 263 (29.3) 378 (42.1) 45 (16.7) 69 (25.7) 21 (7.8) 55 (20.5) 79 (29.4) 0 0 4 (9.5) 16 (38.1) 22 (52.4) 9 (23.1) 7 (18.0) 4 (10.3) 7 (18.0) 12 (30.8) <0.001 Marital status c Single or never married/unmarried or domestic partner Married Separated/divorced Widowed 230 (19.7) 814 (69.6) 80 (6.8) 45 (3.9) 99 (11.8) 661 (79.0) 47 (5.6) 30 (3.6) 113 (45.0) 96 (38.3) 27 (10.8) 15 (6.0) 8 (20.0) 29 (72.5) 3 (7.5) 0 10 (24.4) 28 (68.3) 3 (7.3) 0 <0.001 Annual household income <$50,000 $50,000-$74,999 $75,000-$99,999 $100,000-$149,999 $150,000-$199,999 ≥$200,000 190 (20.0) 155 (16.3) 128 (13.5) 174 (18.3) 131 (13.8) 173 (18.2) 75 (11.3) 95 (14.3) 84 (12.6) 142 (21.4) 111 (16.7) 158 (23.8) 96 (43.4) 53 (24.0) 34 (15.4) 19 (8.6) 13 (5.9) 6 (2.7) 6 (18.8) 2 (6.3) 7 (21.9) 9 (28.1) 2 (6.3) 6 (18.8) 13 (39.4) 5 (15.2) 3 (9.1) 4 (12.1) 5 (15.2) 3 (9.1) <0.001 Type of health insurance d Private Medicaid Medicare Other 867 (74.8) 58 (5.0) 214 (18.5) 20 (1.7) 656 (79.6) 12 (1.5) 142 (17.2) 14 (1.7) 146 (56.6) 42 (16.3) 65 (25.2) 5 (1.9) 36 (92.3) 0 3 (7.7) 0 29 (76.3) 4 (10.5) 4 (10.5) 1 (2.6) <0.001 History of tobacco use e Never Current Past 773 (68.4) 70 (6.2) 288 (25.5) 565 (70.5) 41 (5.1) 196 (24.4) 149 (60.1) 23 (9.3) 76 (30.7) 37 (92.5) 0 3 (7.5) 22 (53.7) 6 (14.6) 13 (31.7) <0.001 History of alcohol consumption Never Current Past 460 (41.5) 626 (56.5) 23 (2.1) 291 (36.7) 488 (61.5) 15 (1.9) 127 (53.4) 105 (44.1) 6 (2.5) 26 (68.4) 12 (31.6) 0 16 (41.0) 21 (53.9) 2 (5.1) 6 661 (53.2) 582 (46.8) 465 (52.4) 422 (47.6) 138 (50.6) 135 (49.5) 27 (64.3) 15 (35.7) 31 (75.6) 10 (24.4) 0.010 Charlson comorbidity index 0 1 ≥2 1,033 (87.9) 63 (5.4) 79 (6.7) 746 (89.0) 44 (5.3) 48 (5.7) 214 (82.3) 18 (6.9) 28 (10.8) 35 (89.7) 1 (2.6) 3 (7.7) 38 (100.0) 0 0 0.018 Receptor status/subtype HR+/HER2- HER2+ TNBC 607 (65.8) 154 (16.7) 162 (17.6) 455 (68.9) 110 (16.7) 95 (14.4) 111 (55.0) 33 (16.3) 58 (28.7) 18 (62.1) 7 (24.1) 4 (13.8) 23 (71.9) 4 (12.5) 5 (15.6) <0.001 Stage group g 0 I II III IV 220 (18.0) 555 (45.3) 314 (25.7) 122 (10.0) 13 (1.1) 149 (17.1) 419 (48.0) 216 (24.7) 83 (9.5) 6 (0.7) 57 (21.1) 101 (37.4) 76 (28.2) 30 (11.1) 6 (2.2) 10 (23.8) 17 (40.5) 9 (21.4) 6 (14.3) 0 4 (10.3) 18 (46.2) 13 (33.3) 3 (7.7) 1 (2.6) 0.094 Abbreviations: SD, standard deviation; GED, general educational development; HR, hormone receptors; HER2, human epidermal growth factor receptor 2; TNBC, triple negative breast cancer; BCS, breast conserving surgery. Note: Percentages may not be 100 due to rounding. a p -values were calculated using ANOVA for continuous data and Chi-square or Fisher’s exact tests for categorical data. b Age was measured at the time of survey. c Marital status was documented at the time of diagnosis. d Other included 1 uninsured/self-pay, 17 insurance not otherwise specified, 1 TRICARE, and 1 Military. e Tobacco products assessed included cigarette, cigar, pipe, snuff, chew, smokeless, or mixed use with more than one type. f Duration from diagnosis to survey was defined as the duration from the time of cancer diagnosis to the time of survey. g Stage group was defined based on the American Joint Committee on Cancer’s cancer staging. Table 2. Familiarity with integrative medicine modalities among breast cancer patients, overall and by race Type of service Familiarity a Total (N=1,213), N (%) White (n=928), n (%) Black (n=285), n (%) p -value b Acupuncture Not familiar at all (1) Not very familiar (2) Neutral (3) Familiar (4) Very familiar (5) 254 (21.2) 227 (18.9) 147 (12.3) 356 (29.7) 216 (18.0) 169 (18.4) 177 (19.2) 116 (12.6) 287 (31.2) 172 (18.7) 85 (30.5) 50 (17.9) 31 (11.1) 69 (24.7) 44 (15.8) <0.001 Mean (SD) 3.0 (1.4)) 3.1 (1.4) 2.8 (1.5) <0.001 Therapeutic massage Not familiar at all (1) Not very familiar (2) Neutral (3) Familiar (4) Very familiar (5) 170 (14.2) 175 (14.6) 135 (11.3) 444 (37.1) 272 (22.7) 113 (12.3) 134 (14.6) 111 (12.1) 347 (37.9) 211 (23.0) 57 (20.4) 41 (14.6) 24 (8.6) 97 (34.6) 61 (21.8) 0.012 Mean (SD) 3.4 (1.4) 3.4 (1.3) 3.2 (1.5) 0.026 Meditation therapy Not familiar at all (1) Not very familiar (2) Neutral (3) Familiar (4) Very familiar (5) 223 (18.7) 210 (17.6) 193 (16.2) 389 (32.6) 179 (15.0) 155 (16.9) 163 (17.8) 163 (17.8) 302 (32.9) 134 (14.6) 68 (24.6) 47 (17.0) 30 (10.8) 87 (31.4) 45 (16.3) 0.009 Mean (SD) 3.1 (1.4) 3.1 (1.3) 3.0 (1.5) 0.194 Music therapy Not familiar at all (1) Not very familiar (2) Neutral (3) Familiar (4) Very familiar (5) 284 (24.0) 269 (22.7) 213 (18.0) 308 (26.0) 111 (9.4) 217 (23.9) 214 (23.5) 181 (19.9) 221 (24.3) 76 (8.4) 67 (24.3) 55 (19.9) 32 (11.6) 87 (31.5) 35 (12.7) 0.001 Mean (SD) 2.7 (1.3) 2.7 (1.3) 2.9 (1.4) 0.040 Yoga therapy Not familiar at all (1) Not very familiar (2) Neutral (3) Familiar (4) Very familiar (5) 236 (20.1) 194 (16.6) 191 (16.3) 374 (31.9) 177 (15.1) 161 (17.9) 141 (15.7) 167 (18.6) 294 (32.7) 136 (15.1) 75 (27.5) 53 (19.4) 24 (8.8) 80 (29.3) 41 (15.0) <0.001 Mean (SD) 3.1 (1.4) 3.1 (1.3) 2.8 (1.5) 0.008 Abbreviation: SD, standard deviation. Note: Percentages may not be 100 due to rounding. a Familiarity was assessed by asking participants how familiar they were with integrative medicine modalities. b p -values were calculated using Student’s t tests for continuous data and Chi-square tests for categorical data. Table 3. Multivariable regression models for familiarity, interest, and self-reported use of different integrative medicine modalities among breast cancer patients, comparing Black patients with White patients Familiarity a Interest b Self-reported use c Type of service aOR d (95% CI) p -value aOR d (95% CI) p -value aOR d (95% CI) p -value Acupuncture 0.60 (0.41-0.87) 0.007 1.12 (0.76-1.65) 0.568 0.49 (0.29-0.84) 0.009 Therapeutic massage 0.91 (0.63-1.33) 0.638 1.86 (1.25-2.77) 0.002 0.83 (0.53-1.30) 0.413 Meditation therapy 1.01 (0.69-1.46) 0.982 2.03 (1.37-3.00) <0.001 0.82 (0.47-1.43) 0.483 Music therapy 1.26 (0.87-1.84) 0.226 2.68 (1.80-3.99) <0.001 1.65 (0.82-3.32) 0.164 Yoga therapy 0.71 (0.49-1.04) 0.077 2.10 (1.41-3.12) <0.001 0.67 (0.37-1.20) 0.179 Abbreviations: aOR, adjusted odds ratio; CI, confidence interval. Note: Multivariable proportional odds were modeled for familiarity with and interest in using different integrative medicine (IM) modalities, while multivariable binomial logistic regression was modeled for self-report of having used these IM modalities in the past. a Familiarity was assessed by asking participants how familiar they were with these IM modalities. b Interest was assessed by asking participants how interested they would be in these IM modalities if offered at the center. c Participants were asked about these IM modalities they have used in the past. d Adjusted for age, highest level of education, marital status, annual household income, type of health insurance, Charlson comorbidity index, hormone receptor status/subtype, and stage group. Table 4. Interest in using integrative medicine modalities among breast cancer patients, overall and by race Type of service Interest a Total (N=1,213), N (%) White (n=928), n (%) Black (n=285), n (%) p -value b Acupuncture Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 300 (26.3) 143 (12.5) 197 (17.3) 245 (21.5) 255 (22.4) 231 (26.1) 116 (13.1) 164 (18.5) 185 (20.9) 190 (21.4) 69 (27.2) 27 (10.6) 33 (13.0) 60 (23.6) 65 (25.6) 0.151 Mean (SD) 3.0 (1.5) 3.0 (1.5) 3.1 (1.6) 0.294 Therapeutic massage Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 196 (16.8) 80 (6.9) 157 (13.5) 339 (29.1) 394 (33.8) 165 (18.4) 67 (7.5) 131 (14.6) 246 (27.4) 288 (32.1) 31 (11.5) 13 (4.8) 26 (9.7) 93 (34.6) 106 (39.4) 0.001 Mean (SD) 3.6 (1.4) 3.5 (1.5) 3.9 (1.3) <0.001 Meditation therapy Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 243 (21.5) 131 (11.6) 224 (19.8) 284 (25.1) 248 (22.0) 203 (23.3) 109 (12.5) 185 (21.2) 204 (23.4) 172 (19.7) 40 (15.6) 22 (8.6) 39 (15.2) 80 (31.1) 76 (29.6) <0.001 Mean (SD) 3.1 (1.4) 3.0 (1.4) 3.5 (1.4) <0.001 Music therapy Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 252 (22.7) 150 (13.5) 259 (23.4) 252 (22.7) 196 (17.7) 218 (25.4) 130 (15.2) 203 (23.7) 181 (21.1) 126 (14.7) 34 (13.6) 20 (8.0) 56 (22.3) 71 (28.3) 70 (27.9) <0.001 Mean (SD) 3.0 (1.4) 2.8 (1.4) 3.5 (1.3) <0.001 Yoga therapy Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 250 (22.2) 111 (9.8) 210 (18.6) 294 (26.1) 263 (23.3) 205 (23.4) 94 (10.7) 178 (20.3) 213 (24.3) 186 (21.2) 45 (17.9) 17 (6.8) 32 (12.7) 81 (32.0) 77 (30.6) <0.001 Mean (SD) 3.2 (1.5) 3.1 (1.5) 3.5 (1.4) <0.001 Abbreviation: SD, standard deviation. Note: Percentages may not be 100 due to rounding. a Interest was assessed by asking participants how interested they would be in these integrative medicine modalities if offered at the center. b p -values were calculated using Student’s t tests for continuous data and Chi-square tests for categorical data. Table 5. Symptoms as facilitators for interest in using any integrative medicine modality among breast cancer patients, overall and by race Symptoms as facilitators a Total (N=1,213), N (%) White (n=928), n (%) Black (n=285), n (%) p -value b Hot flashes Not interested (1,2) Neutral (3) Interested (4,5) 410 (36.9) 199 (17.9) 503 (45.2) 330 (38.1) 154 (17.8) 382 (44.1) 80 (32.5) 45 (18.3) 121 (49.2) 0.254 Chemotherapy-induced neuropathy Not interested (1,2) Neutral (3) Interested (4,5) 453 (41.4) 213 (19.5) 429 (39.2) 354 (41.9) 170 (20.1) 321 (38.0) 99 (39.6) 43 (17.2) 108 (43.2) 0.297 Nausea Not interested (1,2) Neutral (3) Interested (4,5) 487 (45.3) 259 (24.1) 329 (30.6) 375 (45.0) 207 (24.8) 252 (30.2) 112 (46.5) 52 (21.6) 77 (32.0) 0.579 Joint pain Not interested (1,2) Neutral (3) Interested (4,5) 223 (19.4) 150 (13.1) 774 (67.5) 175 (20.0) 121 (13.8) 580 (66.2) 48 (17.7) 29 (10.7) 194 (71.6) 0.227 Back or other pain Not interested (1,2) Neutral (3) Interested (4,5) 221 (19.5) 152 (13.4) 762 (67.1) 169 (19.5) 126 (14.6) 571 (65.9) 52 (19.3) 26 (9.7) 191 (71.0) 0.108 Depression/mood change Not interested (1,2) Neutral (3) Interested (4,5) 319 (28.8) 213 (19.2) 577 (52.0) 238 (27.7) 170 (19.8) 451 (52.5) 81 (32.4) 43 (17.2) 126 (50.4) 0.313 Fatigue/tiredness Not interested (1,2) Neutral (3) Interested (4,5) 245 (21.6) 164 (14.5) 726 (64.0) 184 (21.2) 129 (14.8) 557 (64.0) 61 (23.0) 35 (13.2) 169 (63.8) 0.705 Anxiety/stress reduction Not interested (1,2) Neutral (3) Interested (4,5) 248 (22.3) 167 (15.0) 699 (62.8) 192 (22.3) 125 (14.5) 544 (63.2) 56 (22.1) 42 (16.6) 155 (61.3) 0.711 Note: Percentages may not be 100 due to rounding. a Symptoms as facilitators were assessed by asking participants how interested they would be in any integrative medicine modality if specifically treated the symptoms above. b p -values were calculated using Chi-square tests. Table 6. Facilitators for interest in using integrative medicine modalities among breast cancer patients, overall and by race Type of service Facilitator Total (N=1,213), N (%) White (n=928), n (%) Black (n=285), n (%) p -value a Acupuncture Recommendation from your doctor or nurse b Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 206 (18.1) 101 (8.9) 186 (16.3) 320 (28.1) 328 (28.8) 141 (16.0) 79 (9.0) 152 (17.2) 252 (28.6) 258 (29.3) 65 (25.1) 22 (8.5) 34 (13.1) 68 (26.3) 70 (27.0) 0.017 Cost not being a barrier c Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 201 (18.0) 96 (8.6) 182 (16.3) 261 (23.3) 379 (33.9) 141 (16.3) 74 (8.6) 149 (17.3) 201 (23.3) 299 (34.6) 60 (23.5) 22 (8.6) 33 (12.9) 60 (23.5) 80 (31.4) 0.073 Being covered by health insurance d Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 207 (18.4) 90 (8.0) 160 (14.2) 267 (23.8) 400 (35.6) 145 (16.7) 68 (7.8) 130 (15.0) 207 (23.9) 318 (36.6) 62 (24.2) 22 (8.6) 30 (11.7) 60 (23.4) 82 (32.0) 0.065 Price willing to pay out of pocket for a session $0 $1-$19 $20-$39 $40-$59 $60-$79 $80-$99 $100+ 433 (40.1) 152 (14.1) 216 (20.0) 162 (15.0) 52 (4.8) 36 (3.3) 30 (2.8) 303 (36.4) 116 (13.9) 183 (22.0) 131 (15.8) 43 (5.2) 33 (4.0) 23 (2.8) 130 (52.2) 36 (14.5) 33 (13.3) 31 (12.5) 9 (3.6) 3 (1.2) 7 (2.8) <0.001 Therapeutic massage Recommendation from your doctor or nurse b Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 106 (9.1) 46 (3.9) 147 (12.6) 414 (35.4) 458 (39.1) 80 (8.9) 34 (3.8) 122 (13.6) 317 (35.3) 345 (38.4) 26 (9.5) 12 (4.4) 25 (9.2) 97 (35.5) 113 (41.4) 0.402 Cost not being a barrier c Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 104 (9.1) 50 (4.4) 141 (12.3) 337 (29.5) 512 (44.8) 79 (9.0) 41 (4.7) 116 (13.2) 250 (28.5) 391 (44.6) 25 (9.4) 9 (3.4) 25 (9.4) 87 (32.6) 121 (45.3) 0.344 Being covered by health insurance d Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 103 (8.9) 49 (4.3) 123 (10.7) 346 (30.0) 531 (46.1) 79 (9.0) 38 (4.3) 101 (11.5) 254 (28.9) 406 (46.2) 24 (8.8) 11 (4.0) 22 (8.0) 92 (33.6) 125 (45.6) 0.414 Price willing to pay out of pocket for a session $0 $1-$19 $20-$39 $40-$59 $60-$79 $80-$99 $100+ 268 (24.2) 179 (16.2) 267 (24.1) 198 (17.9) 103 (9.3) 52 (4.7) 41 (3.7) 178 (21.1) 128 (15.2) 219 (25.9) 159 (18.8) 90 (10.7) 41 (4.9) 30 (3.6) 90 (34.2) 51 (19.4) 48 (18.3) 39 (14.8) 13 (4.9) 11 (4.2) 11 (4.2) <0.001 Meditation therapy Recommendation from your doctor or nurse b Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 162 (14.2) 97 (8.5) 220 (19.3) 354 (31.1) 307 (26.9) 123 (14.0) 81 (9.2) 187 (21.3) 271 (30.8) 218 (24.8) 39 (15.0) 16 (6.2) 33 (12.7) 83 (31.9) 89 (34.2) 0.002 Cost not being a barrier c Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 163 (14.7) 86 (7.7) 212 (19.1) 298 (26.8) 353 (31.7) 125 (14.6) 71 (8.3) 180 (21.1) 226 (26.4) 253 (29.6) 38 (14.8) 15 (5.8) 32 (12.5) 72 (28.0) 100 (38.9) 0.005 Being covered by health insurance d Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 161 (14.3) 86 (7.7) 202 (18.0) 305 (27.2) 369 (32.9) 124 (14.3) 73 (8.4) 175 (20.2) 228 (26.4) 265 (30.6) 37 (14.3) 13 (5.0) 27 (10.5) 77 (29.8) 104 (40.3) 0.001 Price willing to pay out of pocket for a session $0 $1-$19 $20-$39 $40-$59 $60-$79 $80-$99 $100+ 446 (41.8) 224 (21.0) 222 (20.8) 116 (10.9) 25 (2.3) 19 (1.8) 15 (1.4) 327 (40.1) 178 (21.8) 177 (21.7) 92 (11.3) 19 (2.3) 14 (1.7) 8 (1.0) 119 (47.2) 46 (18.3) 45 (17.9) 24 (9.5) 6 (2.4) 5 (2.0) 7 (2.8) 0.128 Music therapy Recommendation from your doctor or nurse b Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 177 (15.9) 117 (10.5) 251 (22.6) 314 (28.2) 254 (22.8) 139 (16.2) 103 (12.0) 206 (24.0) 233 (27.1) 178 (20.7) 38 (15.0) 14 (5.5) 45 (17.7) 81 (31.9) 76 (29.9) <0.001 Cost not being a barrier c Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 177 (16.2) 109 (10.0) 241 (22.1) 264 (24.2) 300 (27.5) 143 (17.0) 98 (11.7) 198 (23.5) 196 (23.3) 206 (24.5) 34 (13.6) 11 (4.4) 43 (17.2) 68 (27.2) 94 (37.6) <0.001 Being covered by health insurance d Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 176 (16.1) 104 (9.5) 234 (21.5) 281 (25.8) 296 (27.1) 143 (17.0) 94 (11.2) 194 (23.1) 207 (24.6) 202 (24.1) 33 (13.2) 10 (4.0) 40 (15.9) 74 (29.5) 94 (37.5) <0.001 Price willing to pay out of pocket for a session $0 $1-$19 $20-$39 $40-$59 $60-$79 $80-$99 $100+ 531 (50.7) 198 (18.9) 176 (16.8) 96 (9.2) 23 (2.2) 9 (0.9) 15 (1.4) 403 (50.3) 152 (19.0) 140 (17.5) 74 (9.2) 17 (2.1) 7 (0.9) 9 (1.1) 128 (52.0) 46 (18.7) 36 (14.6) 22 (8.9) 6 (2.4) 2 (0.8) 6 (2.4) 0.756 Yoga therapy Recommendation from your doctor or nurse b Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 176 (15.6) 78 (6.9) 201 (17.8) 373 (33.1) 300 (26.6) 132 (15.1) 68 (7.8) 170 (19.5) 281 (32.2) 222 (25.4) 44 (17.3) 10 (3.9) 31 (12.2) 92 (36.1) 78 (30.6) 0.009 Cost not being a barrier c Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 163 (14.9) 80 (7.3) 197 (18.0) 296 (27.0) 361 (32.9) 123 (14.5) 69 (8.1) 169 (19.9) 221 (26.0) 268 (31.5) 40 (16.2) 11 (4.5) 28 (11.3) 75 (30.4) 93 (37.7) 0.004 Being covered by health insurance d Not interested at all (1) Not very interested (2) Neutral (3) Interested (4) Very interested (5) 175 (15.7) 71 (6.4) 186 (16.7) 302 (27.0) 383 (34.3) 133 (15.5) 62 (7.2) 160 (18.6) 222 (25.8) 283 (32.9) 42 (16.3) 9 (3.5) 26 (10.1) 80 (31.1) 100 (38.9) 0.002 Price willing to pay out of pocket for a session $0 $1-$19 $20-$39 $40-$59 $60-$79 $80-$99 $100+ 404 (37.7) 258 (24.1) 247 (23.1) 101 (9.4) 31 (2.9) 12 (1.1) 18 (1.7) 295 (35.8) 209 (25.4) 196 (23.8) 77 (9.3) 24 (2.9) 10 (1.2) 13 (1.6) 109 (44.1) 49 (19.8) 51 (20.7) 24 (9.7) 7 (2.8) 2 (0.8) 5 (2.0) 0.298 Note: Percentages may not be 100 due to rounding. a p -values were calculated using Chi-square tests. b Recommendation from your doctor or nurse was assessed by asking participants how interested they would be to have any integrative medicine modality if their doctor or nurse recommended it. c Cost not being a barrier was assessed by asking participants how interested they would be to have any integrative medicine modality if cost was not a barrier. d Being covered by health insurance was assessed by asking participants how interested they would be to have any integrative medicine modality if their health insurance paid for it. Table 7. Self-reported use of integrative medicine modalities among breast cancer patients, overall and by race Type of service Total (N=1,213), N (%) White (n=928), n (%) Black (n=285), n (%) p -value a Acupuncture No Yes 897 (73.9) 316 (26.1) 654 (70.5) 274 (29.5) 243 (85.3) 42 (14.7) <0.001 Therapeutic massage No Yes 708 (58.4) 505 (41.6) 530 (57.1) 398 (42.9) 178 (62.5) 107 (37.5) 0.109 Meditation therapy No Yes 989 (81.5) 224 (18.5) 754 (81.3) 174 (18.8) 235 (82.5) 50 (17.5) 0.646 Music therapy No Yes 1,120 (92.3) 93 (7.7) 867 (93.4) 61 (6.6) 253 (88.8) 32 (11.2) 0.009 Yoga therapy No Yes 983 (81.0) 230 (19.0) 735 (79.2) 193 (20.8) 248 (87.0) 37 (13.0) 0.003 Note: Percentages may not be 100 due to rounding. a p -values were calculated using Chi-square tests. b Participants were asked about these integrative medicine modalities they have used in the past. Table 8. Barriers to using any integrative medicine modality among breast cancer patients, overall and by race Barrier a Total (N=1,213), N (%) White (n=928) n (%) Black (n=285) n (%) p -value b Cost/money No Yes 765 (63.1) 448 (36.9) 637 (68.6) 291 (31.4) 128 (44.9) 157 (55.1) <0.001 Lack of access to services No Yes 963 (79.4) 250 (20.6) 748 (80.6) 180 (19.4) 215 (75.4) 70 (24.6) 0.059 Lack of transportation to service-providing facilities No Yes 1,090 (89.9) 123 (10.1) 842 (90.7) 86 (9.3) 248 (87.0) 37 (13.0) 0.069 Lack of time No Yes 859 (70.8) 354 (29.2) 629 (67.8) 299 (32.2) 230 (80.7) 55 (19.3) <0.001 Lack of interest No Yes 1,017 (83.8) 196 (16.2) 768 (82.8) 160 (17.2) 249 (87.4) 36 (12.6) 0.064 Unaware of benefits of these services No Yes 889 (73.3) 324 (26.7) 706 (76.1) 222 (23.9) 183 (64.2) 102 (35.8) <0.001 Low confidence about the benefits on these services No Yes 1,102 (90.9) 111 (9.2) 844 (91.0) 84 (9.1) 258 (90.5) 27 (9.5) 0.829 Lack of trusted information on these services No Yes 1,128 (93.0) 85 (7.0) 865 (93.2) 63 (6.8) 263 (92.3) 22 (7.7) 0.590 Note: Percentages may not be 100 due to rounding. a Barriers were assessed by asking participants what, in general, prevents them from using any integrative medicine modality. b p -values were calculated using Chi-square tests. Additional Declarations Competing interest reported. J.Q.F., J.B.S., F.Z., and D.H. have no relevant financial or non-financial conflict of interests to disclose. R.N. disclosed advisory board involvement with and research funding from Arvinas, AstraZeneca, BeyondSpring, Celgene, FujiFilm, Genentech/Roche, Gilead, Infinity, iTeos, Merck, OBI Pharma, OncoSec, Pfizer, Relay Therapeutics, SeaGen, Sun Pharma, and Taiho. O.I.O. disclosed financial relationships with CancerIQ, 54gnene, HealthWell Solutions, Tempus; research funding from Ayala Pharmaceuticals, Cepheid, Color Genomics, Novartis, and Roche/Genentech. Cite Share Download PDF Status: Under Review Version 1 posted Editorial decision: Revision requested 06 Mar, 2024 Reviews received at journal 06 Mar, 2024 Reviews received at journal 20 Feb, 2024 Reviewers agreed at journal 09 Feb, 2024 Reviewers invited by journal 08 Feb, 2024 Editor assigned by journal 30 Jan, 2024 Submission checks completed at journal 30 Jan, 2024 First submitted to journal 29 Jan, 2024 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3909360","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":269963363,"identity":"9680e496-83bd-40f0-b2b2-020aec1e65d1","order_by":0,"name":"Jincong Q. Freeman","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA5ElEQVRIiWNgGAWjYBACxoaDD0C0HAMDD8MBqKABAS2HwQqMidfCwMAMVpDYANQCA/i1MDceZvvwoWJb+objZw8e+FFTK8fA3rxNgoDDmGfOOHM7d8OZvISDPceOGzPwHCsjoOX8YWbeNqCWGzwGhxnYjiU2SOSYEbSF+e+/2+kGYC3/gFrk3xChhbHhdgJYC2NbDdAWHsJaGHuO3TaceSbH4GBv3wFjNp60Ygt8WgxnHGZm+FFzW57v+BnjDz++1cnxsx/eeAO/lgMofGAI4FMOAvL8DSj8OkIaRsEoGAWjYAQCAJCcUgv+ya85AAAAAElFTkSuQmCC","orcid":"","institution":"Department of Public Health Sciences, The University of Chicago","correspondingAuthor":true,"prefix":"","firstName":"Jincong","middleName":"Q.","lastName":"Freeman","suffix":""},{"id":269963364,"identity":"31abbbe5-33df-4789-9b0e-7a5cc24a6e03","order_by":1,"name":"Jori B. Sheade","email":"","orcid":"","institution":"Northwestern Medicine Lake Forest Hospital","correspondingAuthor":false,"prefix":"","firstName":"Jori","middleName":"B.","lastName":"Sheade","suffix":""},{"id":269963365,"identity":"44bf4d9e-f957-4cef-996f-f273e74bc0b0","order_by":2,"name":"Fangyuan Zhao","email":"","orcid":"","institution":"Department of Public Health Sciences, The University of Chicago","correspondingAuthor":false,"prefix":"","firstName":"Fangyuan","middleName":"","lastName":"Zhao","suffix":""},{"id":269963366,"identity":"709f96b6-9434-4f20-8481-1c31612f02e3","order_by":3,"name":"Olufunmilayo I. Olopade","email":"","orcid":"","institution":"Center for Clinical Cancer Genetics \u0026 Global Health, The University of Chicago","correspondingAuthor":false,"prefix":"","firstName":"Olufunmilayo","middleName":"I.","lastName":"Olopade","suffix":""},{"id":269963367,"identity":"7bfc8635-16d1-4222-a110-bbd5b606632c","order_by":4,"name":"Dezheng Huo","email":"","orcid":"","institution":"Department of Public Health Sciences, The University of Chicago","correspondingAuthor":false,"prefix":"","firstName":"Dezheng","middleName":"","lastName":"Huo","suffix":""},{"id":269963368,"identity":"bd3aea9e-c690-413a-8581-a88cefcf2a29","order_by":5,"name":"Rita Nanda","email":"","orcid":"","institution":"Section of Hematology/Oncology, Department of Medicine, The University of Chicago","correspondingAuthor":false,"prefix":"","firstName":"Rita","middleName":"","lastName":"Nanda","suffix":""}],"badges":[],"createdAt":"2024-01-29 18:59:12","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3909360/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3909360/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":50516365,"identity":"9116231f-e460-4511-8935-9444d614a5f2","added_by":"auto","created_at":"2024-02-01 16:58:57","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":943045,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3909360/v1/4eeb1600-773a-4448-b45a-1d1459cc264e.pdf"}],"financialInterests":"Competing interest reported. J.Q.F., J.B.S., F.Z., and D.H. have no relevant financial or non-financial conflict of interests to disclose. R.N. disclosed advisory board involvement with and research funding from Arvinas, AstraZeneca, BeyondSpring, Celgene, FujiFilm, Genentech/Roche, Gilead, Infinity, iTeos, Merck, OBI Pharma, OncoSec, Pfizer, Relay Therapeutics, SeaGen, Sun Pharma, and Taiho. O.I.O. disclosed financial relationships with CancerIQ, 54gnene, HealthWell Solutions, Tempus; research funding from Ayala Pharmaceuticals, Cepheid, Color Genomics, Novartis, and Roche/Genentech.","formattedTitle":"Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer","fulltext":[{"header":"Introduction","content":"\u003cp\u003eBreast cancer is the most common cancer type, with more than 3.6\u0026nbsp;million people living with breast cancer in the United States (U.S.) [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. Breast cancer and its treatment can be associated with numerous side effects and symptoms, from cancer pain to lymphedema to hot flashes, [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e] that can negatively impact patients\u0026rsquo; treatment adherence and quality of life [\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. Reduction of side effects and management of symptoms typically consists of further medications, which carry their own adverse effect profiles. In 2017, the Society for Integrative Oncology (SIO) performed a systemic review focusing on randomized controlled trials from 1990 through 2015 of the use of integrative medicine (IM) modalities during and after breast cancer treatment [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e]. This resulted in a set of evidence-based practice guidelines on the use of IM in breast cancer, which was subsequently endorsed by the American Society of Clinical Oncology (ASCO) in 2018 [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e]. IM modalities, including acupuncture, therapeutic massage, meditation therapy, music therapy, and yoga therapy all have received ASCO\u0026rsquo;s endorsement for the treatment or management of various side effects and symptoms, particularly: hot flashes, nausea, anxiety or stress reduction, depression or mood disorders, and improving quality of life [\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e].\u003c/p\u003e \u003cp\u003eA recent study has documented that more than 50.0% of cancer patients and their caregivers are familiar with acupuncture, yoga therapy, and meditation therapy [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e]. Multiple previous studies have reported breast and gynecological cancer patients\u0026rsquo; growing interest in and demand for IM, however, these studies included only White female patients [\u003cspan additionalcitationids=\"CR8 CR9\" citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. Use of IM has increased in recent decades [\u003cspan additionalcitationids=\"CR12\" citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. A survey conducted in breast cancer survivors found that more than 80.0% of the survivors had either used a complementary and alternative therapy or visited a therapist in the past [\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. Black race and lower socioeconomic status (SES) have historically been associated with lower prevalence of IM utilization among U.S. adults, according to a study using the 2002 National Health Interview Survey [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e]. Therefore, IM services are generally marketed toward White populations and those with higher SES. However, little is known about familiarity, interest, and use of IM among Black or African American breast cancer patients and survivors.\u003c/p\u003e \u003cp\u003eTo date, the best study about racial differences in interest and use of IM comes from a 2017 study out of the University of Texas MD Anderson Cancer Center, which surveyed 165 cancer patients, 43% of which were Black or African Americans, at an urban community hospital about interest and use of complementary and alternative therapies [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. The study found that 90.6% of the patients were interested in therapeutic massage, followed by 72.7% in meditation therapy, 69.8% in yoga therapy, and 49.7% in acupuncture [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. However, most were unprofessionally guided use, and both past and current IM use were low. In this study, 13.8% of the Black patients had used yoga therapy as compared to 42.9% of Asian and 25.7% of White patients, with no significant differences among these racial groups based on a Pearson\u0026rsquo;s Chi-square test. Moreover, the study did not perform multivariable regression analyses due to the small sample size [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e].\u003c/p\u003e \u003cp\u003ePrior studies are small and descriptive, with the majority of cancer patients and survivors being White. Additionally, there is paucity of data on racial differences in familiarity, interest, and use of IM specifically among breast cancer patients. To fill these gaps in the literature, we sought to assess racial differences in familiarity, interest, and use of five ASCO-endorsed IM modalities for breast cancer symptom management: acupuncture, therapeutic massage, meditation therapy, music therapy, and yoga therapy in a large cohort of patients with breast cancer having been treated at the University of Chicago Medicine.\u003c/p\u003e"},{"header":"Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003eStudy design and study population\u003c/h2\u003e \u003cp\u003eWe conducted a cross-sectional survey among breast cancer patients who were enrolled in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort (ChiMEC). Briefly, ChiMEC is a hospital-based study having been enrolling patients diagnosed with breast cancer since 1993. Detailed information of ChiMEC has been previously published [\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e]. Eligible participants were aged 18 years or older. From July to September 2021, a REDCap survey was sent to 2,788 ChiMEC participants who consented to be followed up for subsequent surveys. All patients provided their written informed consent prior to study participation. The University of Chicago Institutional Review Board reviewed and approved this study.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003eMeasures of key variables\u003c/h2\u003e \u003cp\u003eFamiliarity was measured by asking participants how familiar they were with these types of IM, using a 5-point Likert scale including not familiar at all, not very familiar, neutral, familiar, and very familiar. Interest was measured by asking participants how interested they would be in these IM modalities if offered at the center, using a 5-point Likert scale including not interested at all, not very interested, neutral, interested, and very interested.\u003c/p\u003e \u003cp\u003eWe also assessed cancer treatment-related symptoms as facilitators by asking participants how interested they would be in any type of IM if it treated hot flashes, chemotherapy-induced neuropathy, nausea, joint pain, back or other pain, depression or mood change, fatigue or tiredness, and anxiety or stress reduction. Other facilitating factors for interest included recommendation from a provider, cost not being a barrier, being covered by health insurance, and price willing to pay out-of-pocket for a session.\u003c/p\u003e \u003cp\u003eTo measure use of IM, we asked patients to \u0026ldquo;Select all of the therapies that you have had or received in the past.\u0026rdquo; Response options for each item were yes and no. We also assessed major barriers to IM use, including cost/money, lack of access to services, lack of transportation to service-providing facilities, lack of time, lack of interest, unaware of benefits of these services, low confidence about the benefits on these services, and lack of trusted information on these services by asking what, in general, prevents participants from using any IM modality.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec5\" class=\"Section2\"\u003e \u003ch2\u003eCovariates\u003c/h2\u003e \u003cp\u003eDemographic and behavioral characteristics, including age, race/ethnicity (Asian, Black, Hispanic, and White), highest level of education (High school/GED or less, post high school, trade/technical school, or some college, Associate\u0026rsquo;s degree, Bachelor\u0026rsquo;s degree, and graduate or professional degree), marital status, annual household income, type of health insurance (Medicare, Medicaid, private, and other), and history of tobacco and alcohol consumption (never, current, and past), were collected from the survey. Clinical characteristics such as duration from diagnosis to survey, American Joint Committee on Cancer (AJCC) stage group, hormone receptor (HR) status (HR-positive/ human epidermal growth factor receptor 2 [HER2]-negative, HER2-positive, and triple negative breast cancer [TNBC]), and Charlson comorbidity index (CCI, i.e., 0, 1, and \u0026ge;\u0026thinsp;2) was obtained through clinical chart abstraction.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003eStatistical analysis\u003c/h2\u003e \u003cp\u003eWe calculated means and standard deviations (SD) for continuous data and tabulated frequencies and percentages (%) for categorical data. Demographic, behavioral, and clinical characteristics between racial/ethnic groups were compared using Student\u0026rsquo;s t tests or ANOA for continuous variables and Pearson\u0026rsquo;s chi-square or Fisher\u0026rsquo;s exact tests for categorical variables. Of note, Asian and Hispanic patients were included in the descriptive analysis but were excluded in subsequent analyses due to small group sample size. Multivariable proportional odds were modeled for familiarity with and interest in different IM modalities. Multivariable binary logistic regression was modeled for self-report of having used these modalities in the past. All models were adjusted for age, highest level of education, marital status, annual household income, type of health insurance, CCI, HR status, and AJCC stage group. To assess racial differences in familiarity, interest, and use of IM modalities, we calculated adjusted odds ratios (aOR) and 95% confidence intervals (CI). The level of significance was set at 0.05. All statistical analyses were performed using SAS 9.4 (SAS Institute, Cary, NC).\u003c/p\u003e \u003c/div\u003e"},{"header":"Results","content":"\u003cp\u003e\u003cstrong\u003e\u003cem\u003ePatient characteristics\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe received 1,300 survey responses from ChiMEC participants. Of the total, 71.4% were White, followed by 21.9% Black, 3.3% Asian, and 3.3% Hispanic; 59.1% were aged 40-65 years; 39.3% obtained a graduate or professional degree; 69.6% were married; 74.8% had private insurance and 23.5% were on Medicaid/Medicare; 65.8% were HR-positive/HER2-negative; and 98.9% had stage 0-III disease (Table 1). Given low percentages of Asian and Hispanic respondents, they were excluded in the following analyses. The mean age of White respondents was 61.4 (SD=11.3) years, whereas Black respondents’ mean age was 62.6 (SD=12.3) years. Compared with White patients, Black patients had higher percentages of having obtained high school/GED or less education (16.7% vs. 8.1%), a lower annual household income of less than $50,000 (43.4% vs. 11.3%), been enrolled in Medicaid (16.3% vs. 1.5%) or Medicare (25.2% vs. 17.2%), and a CCI of ≥2 (10.8% vs. 5.7%). A higher percentage of Black patients had TNBC than White patients (28.7% vs. 14.4%) (Table 1).\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eFamiliarity with integrative medicine\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eOverall, 59.8% of the patients were familiar or very familiar with therapeutic massage, followed by 47.7% acupuncture, 47.6% meditation therapy, 47.0% yoga therapy, and 35.4% music therapy. Compared with White patients, Black patients had a higher percentage of being familiar or very familiar with music therapy (44.2% vs. 32.7%). However, a higher percentage of White patients reported being familiar or very familiar with therapeutic massage (60.9% vs. 56.4%), acupuncture (49.9% vs. 40.5%), or yoga therapy (47.8% vs. 44.3%) than Black patients (Table 2). After adjusting for covariates, Black patients were less likely than their White counterparts to be familiar with acupuncture (aOR 0.60, 95% CI: 0.41-0.87). We did not observe differences between Black and White patients in familiarity with music therapy, meditation therapy, therapeutic, or yoga therapy (Table 3).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eInterest in integrative medicine and facilitators\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eOverall, 62.9% of the patients reported being interested or very interested in therapeutic massage, followed by 49.4% yoga therapy, 47.1% meditation therapy, 43.9% acupuncture, and 40.4% music therapy. By race, Black patients had higher percentages of being interested or very interested in therapeutic massage (74.0% vs. 59.5%), yoga therapy (62.6% vs. 45.5%), meditation therapy (60.7% vs. 43.1%), music therapy (56.2% vs. 35.8%), or acupuncture (49.2% vs. 42.3%) than did White patients (Table 4). In the adjusted proportional odds model, Black patients were significantly more interested in the use of music therapy (aOR 2.68, 95% CI: 1.80-3.99), yoga therapy (aOR 2.10, 95% CI: 1.41-3.12), meditation therapy (aOR 2.03, 95% CI: 1.37-3.00), and therapeutic massage (aOR 1.86, 95% CI: 1.25-2.77) than their White counterparts. There was no differences in interest in acupuncture between the racial groups (Table 3).\u0026nbsp;\u0026nbsp;\u003cbr\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eParticipants reported being interested or very interested when asked for interest in any of the IM modalities to address specific symptoms: joint paints due to aromatase inhibitors (Black 71.6% vs. White 66.2%), back pain or other pain (Black 71.0% vs. White 65.9%), fatigue (Black 63.8% vs. White 64.0%), anxiety or stress reduction (Black 61.3% vs. White 63.25), depression or mood changes (Black 50.4% vs. White 52.5%), hot flashes (Black 49.2% vs. White 44.1%), chemotherapy-induced neuropathy (Black 43.2% vs. White 38.0%), and nausea (Black 32.0% vs. White 30.2%). However, there were no significant differences in symptoms as facilitators for interest in IM between the races (Table 5). Generally, Black respondents expressed more interest in IM modalities if they were recommended by their doctors or nurses and were covered by health insurance. Black respondents typically were less willing to pay more than $0-$19 out of pocket for a session of any IM services (Table 6).\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eUse of integrative medicine and barriers\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eOverall, 41.6% of the patients had used therapeutic massage, followed by 26.1% acupuncture, 19.0% yoga therapy, 18.5% meditation therapy, and only 7.7% music therapy. Higher percentages of White patients reported having used therapeutic massage (42.9% vs. 37.5%), acupuncture (29.5% vs. 14.7%), yoga therapy (20.8% vs. 13.0%), and meditation therapy (18.8% vs. 17.5%) than Black patients. However, Black patients had a higher percentage of prior use of music therapy than did White patients (11.2% vs. 6.6%) (Table 7). In the adjusted logistic regression model, there were no differences between Black and White patients in self-reported use of the IM modalities surveyed, with the exception of acupuncture as Black patients were less likely than their White counterparts to have used acupuncture (aOR 0.49, 95% CI: 0.29-0.84) (Table 3).\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eWhen participants were asked about barriers to use of any IM modality, higher percentages of Black patients reported cost (55.1% vs. 31.4%), lack of awareness of benefits of IM services (35.8% vs. 23.9%), lack of access to services (24.6% vs. 19.4%), and lack of transportation to service-providing facilities (13.0% vs. 9.3%) than White patients. White patients had a higher percentage of lack of time as a barrier to use than their Black counterparts (32.2% vs. 19.3%). Of note, confidence in the benefits of IM was high in both races (White 91% vs. Black 90.5%) (Table 8).\u0026nbsp;\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eTo our knowledge, this is of the first and the largest study to examine racial differences in familiarity, interest, and use of five ASCO-endorsed IM modalities and to assess specific symptom-related facilitating factors for interest in, and key barriers to use of, these modalities among U.S. patients with breast cancer.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn this diverse cohort of patients with breast cancer, familiarity of IM modalities was prevalent among Black and White patients. However, higher proportions, ranging from 26.9% to 48.6%, of the patients across the racial groups were still not familiar with these modalities. Black patients were less familiar with acupuncture than their White counterparts, but there were no differences between them in familiarity with therapeutic massage, meditation therapy, music therapy, and yoga therapy. These findings are somewhat consistent with a recent study of familiarity and interest in IM among cancer patients and their caregivers that non-White patients are less familiar with therapeutic massage than White patients, while levels of familiarity with acupuncture, meditation therapy, music therapy, and yoga therapy are similar between White and non-White patients [6]. Our findings suggest that patient education on IM and its associated benefits may be needed among breast cancer patients and survivors in order to increase patients’ knowledge and awareness of IM. Future research may be needed to explore reasons related to level of familiarity and how the findings could help inform and tailor IM education campaigns and programs specifically toward breast cancer patients and survivors.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eWe found that most patients across the two racial groups were interested in the use of IM modalities, and the percentages of interest of IM use also increased when the patients were asked if any of these modalities were treated for a particular symptom such as joint pains, back pain, fatigue, anxiety or stress reduction, hot flashes, and chemotherapy-induced neuropathy. Our finding in increased interest of IM use aligns with a published study that patients who experience back, joint, or other pain are more likely to use acupuncture and therapeutic massage, though racial differences were not assessed [16]. Further, Black patients were twice as likely as their White counterparts to have expressed interest in music therapy, yoga therapy, meditation therapy, and therapeutic massage, which is contrary to prior findings in the general population that conclude Black patients are less interested in IM services than White patients [12]. Breast cancer patients may have unique needs, as a population-based research has indicated that cancer patients and survivors are more likely than the general population to have discussed IM use with a provider and have used these modalities in the past 12 months [17]. Our result also contradicts a recent study finding that levels of interest in IM are similar between non-White and White patients [6]. However, this study sample was relatively small, probably lacking statistical power. In addition, it included patients with different cancer types and their caregivers, and thus, the findings may not be comparable to our cohort of breast cancer patients [6]. It is worth noting that approximately 21.6%-40.6% of the patients across the racial groups reported being not very interested or not interested at all in using these IM modalities, even when they were asked if these modalities addressed specific common cancer treatment-associated symptoms. It is also important to note that most patients expressed greater interest in IM use if recommended by their providers and were willing to pay no more than $19 out of pocket for a session. Our findings indicate that Black patients may be in greater need for IM and that both provision and coverage of these modalities should be integrated as part of standard cancer care and services at comprehensive cancer centers in the U.S.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThe percentages of past use of IM modalities were low among Black and White breast cancer patients; the majority of the patients, between 57.1% and 93.4%, had not used these modalities in the past. These results are in line with a previous study that both past and current use of acupuncture, meditation therapy, yoga therapy, and therapeutic massage were low, ranging from only 5.6% to 46.3% [14]. Compared with White patients, a higher proportion of Black patients reported cost, lack of access to services, unaware of the benefits of these services as major barriers to IM use. Less than 10.0% of both Black and White patients reported low confidence in the benefits of the five surveyed IM modalities. After adjusting for key demographic and clinical characteristics, Black patients in our cohort were significantly less likely than their White counterparts to have used acupuncture, while there were no differences between the racial groups in past use of therapeutic massage, meditation therapy, music therapy, or yoga therapy. Our finding is consistent with the previous study partially that use of yoga therapy was similar between Black and White patients, however, multivariable regression modeling was not performed due to the small sample size [14]. It is important to point out that we did not ask whether the patients had used these IM modalities before, during, and/or after their cancer therapies, which is worth doing in future research to evaluate whether there are racial and ethnic differences in IM utilization over time and how these differences would impact breast cancer patients’ treatment adherence and quality of life. Our findings also suggest that\u0026nbsp;providers at cancer centers\u0026nbsp;should be promoting these IM services as recommended by ASCO guidelines to all patients which, as shown, may be likely to increase interest in breast cancer patients and survivors\u003c/p\u003e\n\u003cp\u003eFurthermore, Black patients with breast cancer more frequently report nonadherence to endocrine therapy than their White counterparts, with side effect profile being one of the main causes of discontinuation [18, 19]. Therefore, the use of IM modalities to reduce side effects from breast cancer treatment and to manage symptoms may lead to greater adherence to endocrine therapy in Black patients. As we have shown Black patients are just as interested, if not more interested, in IM as their White counterparts, and there are likely unmet needs of IM among breast cancer patients, we should ensure equity to access these services for all our breast cancer patients, regardless of race.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eSeveral limitations of this study need to be noted. First, the data collected through the survey were self-reported, which were subject to recall error or social desirability bias. However, we expect such bias to be minimal since our research staff had little interaction with the patients. Therefore, their responses were unlikely influenced. Second, because we did not ask the participants whether they had use these services before their cancer diagnoses, during, and/or after their cancer treatment, with an approximately 47.0% response rate, the percentages of use of these IM modalities may have been either overestimated or underestimated. Third, we were not able to assess unmeasured characteristics, e.g., cultural background/influence, employment status, patient-provider discussion of IM, which might affect or help better explain the observed racial differences in familiarity, interest, and past use of IM. Thus, additional cultural and behavioral factors should be taken into consideration in future research. Lastly, participants in the ChiMEC may not be representative of all U.S. patients with breast cancer or other patient populations, and therefore, limiting the generalizability of our study findings.\u003c/p\u003e\n\u003cp\u003eDespite the above limitations, this study has several strengths. Our study is the largest to date examining racial differences in familiarity, interest, and use of the five ASCO-endorsed IM modalities among patients with breast cancer. Another strength of this study was the inclusion of a racially diverse cohort of patients with breast cancer and key clinical characteristics that previous research was not able to assess.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn conclusion, both Black and White breast cancer patients were familiar with the five ASCO-endorsed IM modalities, but Black patients expressed greater interest in the use of these modalities. There were no racial differences in prior use of IM, except an increased use of acupuncture among White patients. However, Black patients reported more health care and services access-related barriers than did their White counterparts. Promoting benefits of IM among breast cancer patients and facilitating patient-provider discussion of IM use may be needed. Furthermore, breast programs focused on health equity should provide access to these services for all patients.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eData availability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe data analyzed during the current study are not publicly available due to the ethics for patient information but can be made available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe are grateful to the participants who are enrolled in the Chicago Multiethnic Epidemiologic Breast\u0026nbsp;Cancer\u0026nbsp;Cohort. We thank the Iannessa family for their generous donation to support this study and our acupuncture program at the University of Chicago Medicine.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by a donation from the Iannessa family, the National Cancer Institute (P20CA233307), Susan G. Komen® (TREND21675016), Breast Cancer Research Foundation (BCRF-23-071), and the National Institute on Aging under grant award T32AG000243. Its contents are solely the responsibility of the author(s) and do not necessarily represent the official views of the National Institute of Health/National Institute on Aging.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor Contributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eJ.Q.F.:\u003c/strong\u003e Conceptualization, data analysis, creating statistical tables, writing the initial manuscript, and formatting and preparation of manuscript submission.\u0026nbsp;\u003cstrong\u003eJ.B.S.:\u003c/strong\u003e Conceptualization, design, survey development, research implementation,\u0026nbsp;writing the initial manuscript, and formatting and preparation of manuscript submission. \u003cstrong\u003eF.Z.:\u003c/strong\u003e Conceptualization, design, survey development, research implementation, data collection and cleaning. \u003cstrong\u003eO.I.O.:\u003c/strong\u003e Conceptualization, design, research implementation. \u003cstrong\u003eD.H.:\u003c/strong\u003e Conceptualization, design, survey development, research implementation, and overall supervision. \u003cstrong\u003eR.N.:\u003c/strong\u003e Conceptualization, design, survey development, research implementation, and overall supervision.\u0026nbsp;All authors contributed to interpretations of the findings, writing, review, and editing of the manuscript, and approval of the final manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthnics declarations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConflict of interest\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eJ.Q.F., J.B.S., F.Z., and D.H. have no relevant financial or non-financial conflict of interests to disclose. R.N. disclosed advisory board involvement with and research funding from Arvinas, AstraZeneca, BeyondSpring, Celgene, FujiFilm, Genentech/Roche, Gilead, Infinity, iTeos, Merck, OBI Pharma, OncoSec, Pfizer, Relay Therapeutics, SeaGen, Sun Pharma, and Taiho. O.I.O. disclosed financial relationships with CancerIQ, 54gnene, HealthWell Solutions, Tempus; research funding from Ayala Pharmaceuticals, Cepheid, Color Genomics, Novartis, and Roche/Genentech.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthnical approval\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study was conducted in line with the principles of the Declaration of Helsinki. Ethnics approval was granted by the University of Chicago Institutional Review Board.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWritten informed consent was obtained from all patients prior to study enrollment and participation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to publish\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u0026nbsp;\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eCancer Stat Facts : Female Breast Cancer. National Institute of Health. Retrieved Feb 3 from \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://seer.cancer.gov/statfacts/html/breast.html\u003c/span\u003e\u003cspan address=\"https://seer.cancer.gov/statfacts/html/breast.html\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSide Effects of Cancer Treatment. National Cancer Institute. Retrieved Feb 3 from \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.cancer.gov/about-cancer/treatment/side-effects\u003c/span\u003e\u003cspan address=\"https://www.cancer.gov/about-cancer/treatment/side-effects\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eParaskevi T (2012) Quality of Life Outcomes in Patients with Breast Cancer. Oncol Rev 6(1):e2. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi:10.4081/oncol.2012.e2\u003c/span\u003e\u003cspan address=\"https://doi:10.4081/oncol.2012.e2\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGreenlee H, DuPont-Reyes MJ, Balneaves LG et al (2017) Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin 67(3):194\u0026ndash;232. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi:10.3322/caac.21397\u003c/span\u003e\u003cspan address=\"https://doi:10.3322/caac.21397\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLyman GH, Greenlee H, Bohlke K et al (2018) Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol 36(25):2647\u0026ndash;2655. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1200/JCO.2018.79.2721\u003c/span\u003e\u003cspan address=\"10.1200/JCO.2018.79.2721\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLarbi OM, Jiang C, McLane B et al (2021) Interest and Willingness to Pay for Integrative Therapies of Patients With Cancer and Caregivers. JCO Oncol Pract 17(11):e1622\u0026ndash;e1630. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi:10.1200/OP.20.00471\u003c/span\u003e\u003cspan address=\"https://doi:10.1200/OP.20.00471\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGrimm D, Mathes S, Woelber L et al (2021) Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany. Arch Gynecol Obstet 303(5):1315\u0026ndash;1330. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi:10.1007/s00404-020-05880-0\u003c/span\u003e\u003cspan address=\"https://doi:10.1007/s00404-020-05880-0\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSchuerger N, Klein E, Hapfelmeier A, Kiechle M, Brambs C, Paepke D (2019) Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients. Breast Care (Basel) 14(1):35\u0026ndash;40. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi:10.1159/000492235\u003c/span\u003e\u003cspan address=\"https://doi:10.1159/000492235\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHack CC, Fasching PA, Fehm T, de Waal J, Rezai M, Baier B et al (2017) Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study. Integr Cancer Ther 16(2):165\u0026ndash;175. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1177/1534735416668575\u003c/span\u003e\u003cspan address=\"10.1177/1534735416668575\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eViscuse PV, Price K, Millstine D, Bhagra A, Bauer B, Ruddy KJ (2017) Integrative medicine in cancer survivors. Curr Opin Oncol 29(4):235\u0026ndash;242. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1097/CCO.0000000000000376\u003c/span\u003e\u003cspan address=\"10.1097/CCO.0000000000000376\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBoon HS, Olatunde F, Zick SM (2007) Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7:4. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/1472-6874-7-4\u003c/span\u003e\u003cspan address=\"10.1186/1472-6874-7-4\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eTindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997\u0026ndash;2002. Altern Ther Health Med 11(1):42\u0026ndash;49. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://pubmed.ncbi.nlm.nih.gov/15712765/\u003c/span\u003e\u003cspan address=\"https://pubmed.ncbi.nlm.nih.gov/15712765/\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCutshall SM, Cha SS, Ness SM, Stan DL, Christensen SA, Bhagra A et al (2015) Symptom burden and integrative medicine in cancer survivorship. Support Care Cancer 23(10):2989\u0026ndash;2994. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s00520-015-2666-0\u003c/span\u003e\u003cspan address=\"10.1007/s00520-015-2666-0\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eJones D, Cohen L, Rieber AG, Urbauer D, Fellman B, Fisch MJ, Nazario A (2018) Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications. Integr Cancer Ther 17(2):371\u0026ndash;379. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1177/1534735417735892\u003c/span\u003e\u003cspan address=\"10.1177/1534735417735892\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZhao F, Copley B, Niu Q, Liu F, Johnson JA, Sutton T et al (2021) Racial disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer Res Treat 185(3):841\u0026ndash;849. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi:10.1007/s10549-020-05984-w\u003c/span\u003e\u003cspan address=\"https://doi:10.1007/s10549-020-05984-w\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003ePang R, Wang S, Tian L, Lee MC, Do A, Cutshall SM et al (2015) Complementary and Integrative Medicine at Mayo Clinic. Am J Chin Med 43(8):1503\u0026ndash;1513. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://doi:10.1142/S0192415X15500858\u003c/span\u003e\u003cspan address=\"http://doi:10.1142/S0192415X15500858\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J (2011) Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv 5(1):8\u0026ndash;17. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi:10.1007/s11764-010-0153-7\u003c/span\u003e\u003cspan address=\"https://doi:10.1007/s11764-010-0153-7\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSpencer JC, Reeve BB, Troester MA, Wheeler SB (2020) Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors. Psychooncology 29(4):647\u0026ndash;654. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1002/pon.5289\u003c/span\u003e\u003cspan address=\"10.1002/pon.5289\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWheeler SB, Spencer J, Pinheiro LC, Murphy CC, Earp JA, Carey L, Reeder-Hayes KE (2019) Endocrine Therapy Nonadherence and Discontinuation in Black and White Women. J Natl Cancer Inst 111(5):498\u0026ndash;508. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/jnci/djy136\u003c/span\u003e\u003cspan address=\"10.1093/jnci/djy136\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"},{"header":"Tables","content":"\u003cp\u003e\u003cstrong\u003eTable 1.\u003c/strong\u003e Demographic, behavioral, and clinical characteristics of breast cancer patients, overall and by race/ethnicity\u003c/p\u003e\n\u003cdiv align=\"center\"\u003e\n \u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"1039\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCharacteristic\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal (N=1,300),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003eN (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eWhite (n=928),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBlack (n=285),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAsian (n=43),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eHispanic (n=43),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003csup\u003ea\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAge\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e, mean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e61.2 (11.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e61.4 (11.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e62.6 (12.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e54.5 (12.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e52.8 (11.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAge group\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e \u003cstrong\u003e(year)\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026lt;40\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; 40-65\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026gt;65\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e53 (4.1)\u003c/p\u003e\n \u003cp\u003e768 (59.1)\u003c/p\u003e\n \u003cp\u003e479 (36.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e29 (3.1)\u003c/p\u003e\n \u003cp\u003e555 (59.8)\u003c/p\u003e\n \u003cp\u003e344 (37.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e14 (4.9)\u003c/p\u003e\n \u003cp\u003e149 (52.3)\u003c/p\u003e\n \u003cp\u003e122 (42.58)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e5 (11.6)\u003c/p\u003e\n \u003cp\u003e31 (72.1)\u003c/p\u003e\n \u003cp\u003e7 (16.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e5 (11.6)\u003c/p\u003e\n \u003cp\u003e32 (74.4)\u003c/p\u003e\n \u003cp\u003e6 (14.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eHighest level of education\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; High school/GED or less\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Post high school, trade/technical school, or some college\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Associate\u0026rsquo;s degree\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Bachelor\u0026rsquo;s degree\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Graduate or professional degree\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e127 (10.2)\u003c/p\u003e\n \u003cp\u003e202 (16.2)\u003c/p\u003e\n \u003cp\u003e87 (7.0)\u003c/p\u003e\n \u003cp\u003e341 (27.3)\u003c/p\u003e\n \u003cp\u003e491 (39.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e73 (8.1)\u003c/p\u003e\n \u003cp\u003e126 (14.0)\u003c/p\u003e\n \u003cp\u003e58 (6.5)\u003c/p\u003e\n \u003cp\u003e263 (29.3)\u003c/p\u003e\n \u003cp\u003e378 (42.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e45 (16.7)\u003c/p\u003e\n \u003cp\u003e69 (25.7)\u003c/p\u003e\n \u003cp\u003e21 (7.8)\u003c/p\u003e\n \u003cp\u003e55 (20.5)\u003c/p\u003e\n \u003cp\u003e79 (29.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003cp\u003e4 (9.5)\u003c/p\u003e\n \u003cp\u003e16 (38.1)\u003c/p\u003e\n \u003cp\u003e22 (52.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e9 (23.1)\u003c/p\u003e\n \u003cp\u003e7 (18.0)\u003c/p\u003e\n \u003cp\u003e4 (10.3)\u003c/p\u003e\n \u003cp\u003e7 (18.0)\u003c/p\u003e\n \u003cp\u003e12 (30.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMarital status\u003c/strong\u003e\u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u0026nbsp;\u003c/strong\u003eSingle or never married/unmarried or domestic partner\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Married\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Separated/divorced\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Widowed\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e230 (19.7)\u003c/p\u003e\n \u003cp\u003e814 (69.6)\u003c/p\u003e\n \u003cp\u003e80 (6.8)\u003c/p\u003e\n \u003cp\u003e45 (3.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e99 (11.8)\u003c/p\u003e\n \u003cp\u003e661 (79.0)\u003c/p\u003e\n \u003cp\u003e47 (5.6)\u003c/p\u003e\n \u003cp\u003e30 (3.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e113 (45.0)\u003c/p\u003e\n \u003cp\u003e96 (38.3)\u003c/p\u003e\n \u003cp\u003e27 (10.8)\u003c/p\u003e\n \u003cp\u003e15 (6.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e8 (20.0)\u003c/p\u003e\n \u003cp\u003e29 (72.5)\u003c/p\u003e\n \u003cp\u003e3 (7.5)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e10 (24.4)\u003c/p\u003e\n \u003cp\u003e28 (68.3)\u003c/p\u003e\n \u003cp\u003e3 (7.3)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAnnual household income\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026lt;$50,000\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $50,000-$74,999\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $75,000-$99,999\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $100,000-$149,999\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $150,000-$199,999\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026ge;$200,000\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e190 (20.0)\u003c/p\u003e\n \u003cp\u003e155 (16.3)\u003c/p\u003e\n \u003cp\u003e128 (13.5)\u003c/p\u003e\n \u003cp\u003e174 (18.3)\u003c/p\u003e\n \u003cp\u003e131 (13.8)\u003c/p\u003e\n \u003cp\u003e173 (18.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e75 (11.3)\u003c/p\u003e\n \u003cp\u003e95 (14.3)\u003c/p\u003e\n \u003cp\u003e84 (12.6)\u003c/p\u003e\n \u003cp\u003e142 (21.4)\u003c/p\u003e\n \u003cp\u003e111 (16.7)\u003c/p\u003e\n \u003cp\u003e158 (23.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e96 (43.4)\u003c/p\u003e\n \u003cp\u003e53 (24.0)\u003c/p\u003e\n \u003cp\u003e34 (15.4)\u003c/p\u003e\n \u003cp\u003e19 (8.6)\u003c/p\u003e\n \u003cp\u003e13 (5.9)\u003c/p\u003e\n \u003cp\u003e6 (2.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e6 (18.8)\u003c/p\u003e\n \u003cp\u003e2 (6.3)\u003c/p\u003e\n \u003cp\u003e7 (21.9)\u003c/p\u003e\n \u003cp\u003e9 (28.1)\u003c/p\u003e\n \u003cp\u003e2 (6.3)\u003c/p\u003e\n \u003cp\u003e6 (18.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e13 (39.4)\u003c/p\u003e\n \u003cp\u003e5 (15.2)\u003c/p\u003e\n \u003cp\u003e3 (9.1)\u003c/p\u003e\n \u003cp\u003e4 (12.1)\u003c/p\u003e\n \u003cp\u003e5 (15.2)\u003c/p\u003e\n \u003cp\u003e3 (9.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eType of health insurance\u003c/strong\u003e\u003csup\u003ed\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Private\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Medicaid\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Medicare\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Other\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e867 (74.8)\u003c/p\u003e\n \u003cp\u003e58 (5.0)\u003c/p\u003e\n \u003cp\u003e214 (18.5)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;20 (1.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e656 (79.6)\u003c/p\u003e\n \u003cp\u003e12 (1.5)\u003c/p\u003e\n \u003cp\u003e142 (17.2)\u003c/p\u003e\n \u003cp\u003e14 (1.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e146 (56.6)\u003c/p\u003e\n \u003cp\u003e42 (16.3)\u003c/p\u003e\n \u003cp\u003e65 (25.2)\u003c/p\u003e\n \u003cp\u003e5 (1.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e36 (92.3)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003cp\u003e3 (7.7)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e29 (76.3)\u003c/p\u003e\n \u003cp\u003e4 (10.5)\u003c/p\u003e\n \u003cp\u003e4 (10.5)\u003c/p\u003e\n \u003cp\u003e1 (2.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eHistory of tobacco use\u003c/strong\u003e\u003csup\u003ee\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u0026nbsp;\u003c/strong\u003eNever\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Current\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Past\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e773 (68.4)\u003c/p\u003e\n \u003cp\u003e70 (6.2)\u003c/p\u003e\n \u003cp\u003e288 (25.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e565 (70.5)\u003c/p\u003e\n \u003cp\u003e41 (5.1)\u003c/p\u003e\n \u003cp\u003e196 (24.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e149 (60.1)\u003c/p\u003e\n \u003cp\u003e23 (9.3)\u003c/p\u003e\n \u003cp\u003e76 (30.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e37 (92.5)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003cp\u003e3 (7.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e22 (53.7)\u003c/p\u003e\n \u003cp\u003e6 (14.6)\u003c/p\u003e\n \u003cp\u003e13 (31.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eHistory of alcohol consumption\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u0026nbsp;\u003c/strong\u003eNever\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Current\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Past\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e460 (41.5)\u003c/p\u003e\n \u003cp\u003e626 (56.5)\u003c/p\u003e\n \u003cp\u003e23 (2.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e291 (36.7)\u003c/p\u003e\n \u003cp\u003e488 (61.5)\u003c/p\u003e\n \u003cp\u003e15 (1.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e127 (53.4)\u003c/p\u003e\n \u003cp\u003e105 (44.1)\u003c/p\u003e\n \u003cp\u003e6 (2.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e26 (68.4)\u003c/p\u003e\n \u003cp\u003e12 (31.6)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e16 (41.0)\u003c/p\u003e\n \u003cp\u003e21 (53.9)\u003c/p\u003e\n \u003cp\u003e2 (5.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eDuration from diagnosis to survey\u003c/strong\u003e\u003csup\u003ef\u003c/sup\u003e \u003cstrong\u003e(year)\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026le;6\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026gt;6\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e661 (53.2)\u003c/p\u003e\n \u003cp\u003e582 (46.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e465 (52.4)\u003c/p\u003e\n \u003cp\u003e422 (47.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e138 (50.6)\u003c/p\u003e\n \u003cp\u003e135 (49.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e27 (64.3)\u003c/p\u003e\n \u003cp\u003e15 (35.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e31 (75.6)\u003c/p\u003e\n \u003cp\u003e10 (24.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.010\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCharlson comorbidity index\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; 0\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; 1\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026ge;2\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e1,033 (87.9)\u003c/p\u003e\n \u003cp\u003e63 (5.4)\u003c/p\u003e\n \u003cp\u003e79 (6.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e746 (89.0)\u003c/p\u003e\n \u003cp\u003e44 (5.3)\u003c/p\u003e\n \u003cp\u003e48 (5.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e214 (82.3)\u003c/p\u003e\n \u003cp\u003e18 (6.9)\u003c/p\u003e\n \u003cp\u003e28 (10.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e35 (89.7)\u003c/p\u003e\n \u003cp\u003e1 (2.6)\u003c/p\u003e\n \u003cp\u003e3 (7.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e38 (100.0)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.018\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eReceptor status/subtype\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; HR+/HER2-\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; HER2+\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; TNBC\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e607 (65.8)\u003c/p\u003e\n \u003cp\u003e154 (16.7)\u003c/p\u003e\n \u003cp\u003e162 (17.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e455 (68.9)\u003c/p\u003e\n \u003cp\u003e110 (16.7)\u003c/p\u003e\n \u003cp\u003e95 (14.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e111 (55.0)\u003c/p\u003e\n \u003cp\u003e33 (16.3)\u003c/p\u003e\n \u003cp\u003e58 (28.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e18 (62.1)\u003c/p\u003e\n \u003cp\u003e7 (24.1)\u003c/p\u003e\n \u003cp\u003e4 (13.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e23 (71.9)\u003c/p\u003e\n \u003cp\u003e4 (12.5)\u003c/p\u003e\n \u003cp\u003e5 (15.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"38.209817131857555%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eStage group\u003c/strong\u003e\u003csup\u003eg\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; 0\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; I\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; II\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; III\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; IV\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.239653512993263%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e220 (18.0)\u003c/p\u003e\n \u003cp\u003e555 (45.3)\u003c/p\u003e\n \u003cp\u003e314 (25.7)\u003c/p\u003e\n \u003cp\u003e122 (10.0)\u003c/p\u003e\n \u003cp\u003e13 (1.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.164581328200192%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e149 (17.1)\u003c/p\u003e\n \u003cp\u003e419 (48.0)\u003c/p\u003e\n \u003cp\u003e216 (24.7)\u003c/p\u003e\n \u003cp\u003e83 (9.5)\u003c/p\u003e\n \u003cp\u003e6 (0.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.934552454282965%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e57 (21.1)\u003c/p\u003e\n \u003cp\u003e101 (37.4)\u003c/p\u003e\n \u003cp\u003e76 (28.2)\u003c/p\u003e\n \u003cp\u003e30 (11.1)\u003c/p\u003e\n \u003cp\u003e6 (2.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.39461020211742%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e10 (23.8)\u003c/p\u003e\n \u003cp\u003e17 (40.5)\u003c/p\u003e\n \u003cp\u003e9 (21.4)\u003c/p\u003e\n \u003cp\u003e6 (14.3)\u003c/p\u003e\n \u003cp\u003e0\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.127045235803658%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e4 (10.3)\u003c/p\u003e\n \u003cp\u003e18 (46.2)\u003c/p\u003e\n \u003cp\u003e13 (33.3)\u003c/p\u003e\n \u003cp\u003e3 (7.7)\u003c/p\u003e\n \u003cp\u003e1 (2.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"6.929740134744947%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.094\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n \u003c/table\u003e\n\u003c/div\u003e\n\u003cp\u003eAbbreviations: SD, standard deviation; GED, general educational development; HR, hormone receptors; HER2, human epidermal growth factor receptor 2; TNBC, triple negative breast cancer; BCS, breast conserving surgery.\u003c/p\u003e\n\u003cp\u003eNote: Percentages may not be 100 due to rounding.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003e\u003cem\u003ep\u003c/em\u003e-values were calculated using ANOVA for continuous data and Chi-square or Fisher\u0026rsquo;s exact tests for categorical data.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u0026nbsp;\u003c/sup\u003eAge was measured at the time of survey.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ec\u0026nbsp;\u003c/sup\u003eMarital status was documented at the time of diagnosis.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ed\u0026nbsp;\u003c/sup\u003eOther included 1 uninsured/self-pay, 17 insurance not otherwise specified, 1 TRICARE, and 1 Military.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ee\u0026nbsp;\u003c/sup\u003eTobacco products assessed included cigarette, cigar, pipe, snuff, chew, smokeless, or mixed use with more than one type.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ef\u0026nbsp;\u003c/sup\u003eDuration from diagnosis to survey was defined as the duration from the time of cancer diagnosis to the time of survey.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eg\u0026nbsp;\u003c/sup\u003eStage group was defined based on the American Joint Committee on Cancer\u0026rsquo;s cancer staging.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 2.\u0026nbsp;\u003c/strong\u003eFamiliarity with integrative medicine modalities among breast cancer patients, overall and by race\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.47244094488189%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eType of service\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.25984251968504%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eFamiliarity\u003csup\u003ea\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.322834645669293%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal (N=1,213),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003eN (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eWhite (n=928),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBlack (n=285),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.448818897637794%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003csup\u003eb\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.47244094488189%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAcupuncture\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.25984251968504%\" valign=\"top\"\u003e\n \u003cp\u003eNot familiar at all (1)\u003c/p\u003e\n \u003cp\u003eNot very familiar (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eFamiliar (4)\u003c/p\u003e\n \u003cp\u003eVery familiar (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.322834645669293%\" valign=\"top\"\u003e\n \u003cp\u003e254 (21.2)\u003c/p\u003e\n \u003cp\u003e227 (18.9)\u003c/p\u003e\n \u003cp\u003e147 (12.3)\u003c/p\u003e\n \u003cp\u003e356 (29.7)\u003c/p\u003e\n \u003cp\u003e216 (18.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e169 (18.4)\u003c/p\u003e\n \u003cp\u003e177 (19.2)\u003c/p\u003e\n \u003cp\u003e116 (12.6)\u003c/p\u003e\n \u003cp\u003e287 (31.2)\u003c/p\u003e\n \u003cp\u003e172 (18.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e85 (30.5)\u003c/p\u003e\n \u003cp\u003e50 (17.9)\u003c/p\u003e\n \u003cp\u003e31 (11.1)\u003c/p\u003e\n \u003cp\u003e69 (24.7)\u003c/p\u003e\n \u003cp\u003e44 (15.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.448818897637794%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"26.73267326732673%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.782178217821784%\" valign=\"top\"\u003e\n \u003cp\u003e3.0 (1.4))\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e2.8 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.881188118811881%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.47244094488189%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTherapeutic massage\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.25984251968504%\" valign=\"top\"\u003e\n \u003cp\u003eNot familiar at all (1)\u003c/p\u003e\n \u003cp\u003eNot very familiar (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eFamiliar (4)\u003c/p\u003e\n \u003cp\u003eVery familiar (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.322834645669293%\" valign=\"top\"\u003e\n \u003cp\u003e170 (14.2)\u003c/p\u003e\n \u003cp\u003e175 (14.6)\u003c/p\u003e\n \u003cp\u003e135 (11.3)\u003c/p\u003e\n \u003cp\u003e444 (37.1)\u003c/p\u003e\n \u003cp\u003e272 (22.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e113 (12.3)\u003c/p\u003e\n \u003cp\u003e134 (14.6)\u003c/p\u003e\n \u003cp\u003e111 (12.1)\u003c/p\u003e\n \u003cp\u003e347 (37.9)\u003c/p\u003e\n \u003cp\u003e211 (23.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e57 (20.4)\u003c/p\u003e\n \u003cp\u003e41 (14.6)\u003c/p\u003e\n \u003cp\u003e24 (8.6)\u003c/p\u003e\n \u003cp\u003e97 (34.6)\u003c/p\u003e\n \u003cp\u003e61 (21.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.448818897637794%\" valign=\"top\"\u003e\n \u003cp\u003e0.012\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"26.73267326732673%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.782178217821784%\" valign=\"top\"\u003e\n \u003cp\u003e3.4 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e3.4 (1.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e3.2 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.881188118811881%\" valign=\"top\"\u003e\n \u003cp\u003e0.026\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.47244094488189%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMeditation therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.25984251968504%\" valign=\"top\"\u003e\n \u003cp\u003eNot familiar at all (1)\u003c/p\u003e\n \u003cp\u003eNot very familiar (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eFamiliar (4)\u003c/p\u003e\n \u003cp\u003eVery familiar (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.322834645669293%\" valign=\"top\"\u003e\n \u003cp\u003e223 (18.7)\u003c/p\u003e\n \u003cp\u003e210 (17.6)\u003c/p\u003e\n \u003cp\u003e193 (16.2)\u003c/p\u003e\n \u003cp\u003e389 (32.6)\u003c/p\u003e\n \u003cp\u003e179 (15.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e155 (16.9)\u003c/p\u003e\n \u003cp\u003e163 (17.8)\u003c/p\u003e\n \u003cp\u003e163 (17.8)\u003c/p\u003e\n \u003cp\u003e302 (32.9)\u003c/p\u003e\n \u003cp\u003e134 (14.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e68 (24.6)\u003c/p\u003e\n \u003cp\u003e47 (17.0)\u003c/p\u003e\n \u003cp\u003e30 (10.8)\u003c/p\u003e\n \u003cp\u003e87 (31.4)\u003c/p\u003e\n \u003cp\u003e45 (16.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.448818897637794%\" valign=\"top\"\u003e\n \u003cp\u003e0.009\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"26.73267326732673%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.782178217821784%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e3.0 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.881188118811881%\" valign=\"top\"\u003e\n \u003cp\u003e0.194\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.47244094488189%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMusic therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.25984251968504%\" valign=\"top\"\u003e\n \u003cp\u003eNot familiar at all (1)\u003c/p\u003e\n \u003cp\u003eNot very familiar (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eFamiliar (4)\u003c/p\u003e\n \u003cp\u003eVery familiar (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.322834645669293%\" valign=\"top\"\u003e\n \u003cp\u003e284 (24.0)\u003c/p\u003e\n \u003cp\u003e269 (22.7)\u003c/p\u003e\n \u003cp\u003e213 (18.0)\u003c/p\u003e\n \u003cp\u003e308 (26.0)\u003c/p\u003e\n \u003cp\u003e111 (9.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e217 (23.9)\u003c/p\u003e\n \u003cp\u003e214 (23.5)\u003c/p\u003e\n \u003cp\u003e181 (19.9)\u003c/p\u003e\n \u003cp\u003e221 (24.3)\u003c/p\u003e\n \u003cp\u003e76 (8.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e67 (24.3)\u003c/p\u003e\n \u003cp\u003e55 (19.9)\u003c/p\u003e\n \u003cp\u003e32 (11.6)\u003c/p\u003e\n \u003cp\u003e87 (31.5)\u003c/p\u003e\n \u003cp\u003e35 (12.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.448818897637794%\" valign=\"top\"\u003e\n \u003cp\u003e0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"26.73267326732673%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.782178217821784%\" valign=\"top\"\u003e\n \u003cp\u003e2.7 (1.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e2.7 (1.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e2.9 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.881188118811881%\" valign=\"top\"\u003e\n \u003cp\u003e0.040\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.47244094488189%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eYoga therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.25984251968504%\" valign=\"top\"\u003e\n \u003cp\u003eNot familiar at all (1)\u003c/p\u003e\n \u003cp\u003eNot very familiar (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eFamiliar (4)\u003c/p\u003e\n \u003cp\u003eVery familiar (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.322834645669293%\" valign=\"top\"\u003e\n \u003cp\u003e236 (20.1)\u003c/p\u003e\n \u003cp\u003e194 (16.6)\u003c/p\u003e\n \u003cp\u003e191 (16.3)\u003c/p\u003e\n \u003cp\u003e374 (31.9)\u003c/p\u003e\n \u003cp\u003e177 (15.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e161 (17.9)\u003c/p\u003e\n \u003cp\u003e141 (15.7)\u003c/p\u003e\n \u003cp\u003e167 (18.6)\u003c/p\u003e\n \u003cp\u003e294 (32.7)\u003c/p\u003e\n \u003cp\u003e136 (15.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.748031496062993%\" valign=\"top\"\u003e\n \u003cp\u003e75 (27.5)\u003c/p\u003e\n \u003cp\u003e53 (19.4)\u003c/p\u003e\n \u003cp\u003e24 (8.8)\u003c/p\u003e\n \u003cp\u003e80 (29.3)\u003c/p\u003e\n \u003cp\u003e41 (15.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.448818897637794%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"26.73267326732673%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.782178217821784%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.801980198019802%\" valign=\"top\"\u003e\n \u003cp\u003e2.8 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.881188118811881%\" valign=\"top\"\u003e\n \u003cp\u003e0.008\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eAbbreviation: SD, standard deviation.\u003c/p\u003e\n\u003cp\u003eNote: Percentages may not be 100 due to rounding.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003eFamiliarity was assessed by asking participants how familiar they were with integrative medicine modalities.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u003c/sup\u003e \u003cem\u003ep\u003c/em\u003e-values were calculated using Student\u0026rsquo;s t tests for continuous data and Chi-square tests for categorical data.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 3.\u0026nbsp;\u003c/strong\u003eMultivariable regression models for familiarity, interest, and self-reported use of different integrative medicine modalities among breast cancer patients, comparing Black patients with White patients\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"852\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"19.953051643192488%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.901408450704224%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eFamiliarity\u003csup\u003ea\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.450704225352112%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.72300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eInterest\u003csup\u003eb\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"18.427230046948356%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eSelf-reported use\u003csup\u003ec\u003c/sup\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"19.953051643192488%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eType of service\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.901408450704224%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eaOR\u003csup\u003ed\u003c/sup\u003e (95% CI)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.450704225352112%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.72300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eaOR\u003csup\u003ed\u003c/sup\u003e (95% CI)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"18.427230046948356%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eaOR\u003csup\u003ed\u003c/sup\u003e (95% CI)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"19.953051643192488%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAcupuncture\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.901408450704224%\" valign=\"top\"\u003e\n \u003cp\u003e0.60 (0.41-0.87)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.450704225352112%\" valign=\"top\"\u003e\n \u003cp\u003e0.007\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.72300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e1.12 (0.76-1.65)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e0.568\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"18.427230046948356%\" valign=\"top\"\u003e\n \u003cp\u003e0.49 (0.29-0.84)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e0.009\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"19.953051643192488%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTherapeutic massage\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.901408450704224%\" valign=\"top\"\u003e\n \u003cp\u003e0.91 (0.63-1.33)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.450704225352112%\" valign=\"top\"\u003e\n \u003cp\u003e0.638\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.72300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e1.86 (1.25-2.77)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e0.002\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"18.427230046948356%\" valign=\"top\"\u003e\n \u003cp\u003e0.83 (0.53-1.30)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e0.413\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"19.953051643192488%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMeditation therapy\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.901408450704224%\" valign=\"top\"\u003e\n \u003cp\u003e1.01 (0.69-1.46)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.450704225352112%\" valign=\"top\"\u003e\n \u003cp\u003e0.982\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.72300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e2.03 (1.37-3.00)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"18.427230046948356%\" valign=\"top\"\u003e\n \u003cp\u003e0.82 (0.47-1.43)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e0.483\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"19.953051643192488%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMusic therapy\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.901408450704224%\" valign=\"top\"\u003e\n \u003cp\u003e1.26 (0.87-1.84)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.450704225352112%\" valign=\"top\"\u003e\n \u003cp\u003e0.226\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.72300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e2.68 (1.80-3.99)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"18.427230046948356%\" valign=\"top\"\u003e\n \u003cp\u003e1.65 (0.82-3.32)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e0.164\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"19.953051643192488%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eYoga therapy\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.901408450704224%\" valign=\"top\"\u003e\n \u003cp\u003e0.71 (0.49-1.04)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.450704225352112%\" valign=\"top\"\u003e\n \u003cp\u003e0.077\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"17.72300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e2.10 (1.41-3.12)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"18.427230046948356%\" valign=\"top\"\u003e\n \u003cp\u003e0.67 (0.37-1.20)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.272300469483568%\" valign=\"top\"\u003e\n \u003cp\u003e0.179\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eAbbreviations: aOR, adjusted odds ratio; CI, confidence interval.\u003c/p\u003e\n\u003cp\u003eNote: Multivariable proportional odds were modeled for familiarity with and interest in using different integrative medicine (IM) modalities, while multivariable binomial logistic regression was modeled for self-report of having used these IM modalities in the past.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u003c/sup\u003e Familiarity was assessed by asking participants how familiar they were with these IM modalities.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u0026nbsp;\u003c/sup\u003eInterest was assessed by asking participants how interested they would be in these IM modalities if offered at the center.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ec\u003c/sup\u003e Participants were asked about these IM modalities they have used in the past.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ed\u0026nbsp;\u003c/sup\u003eAdjusted for age, highest level of education, marital status, annual household income, type of health insurance, Charlson comorbidity index, hormone receptor status/subtype, and stage group.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 4.\u0026nbsp;\u003c/strong\u003eInterest in using integrative medicine modalities among breast cancer patients, overall and by race\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.3125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eType of service\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"22.65625%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eInterest\u003csup\u003ea\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.40625%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal (N=1,213),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003eN (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eWhite (n=928),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBlack (n=285),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.375%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003csup\u003eb\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.3125%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAcupuncture\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"22.65625%\" valign=\"top\"\u003e\n \u003cp\u003eNot interested at all (1)\u003c/p\u003e\n \u003cp\u003eNot very interested (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eInterested (4)\u003c/p\u003e\n \u003cp\u003eVery interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.40625%\" valign=\"top\"\u003e\n \u003cp\u003e300 (26.3)\u003c/p\u003e\n \u003cp\u003e143 (12.5)\u003c/p\u003e\n \u003cp\u003e197 (17.3)\u003c/p\u003e\n \u003cp\u003e245 (21.5)\u003c/p\u003e\n \u003cp\u003e255 (22.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e231 (26.1)\u003c/p\u003e\n \u003cp\u003e116 (13.1)\u003c/p\u003e\n \u003cp\u003e164 (18.5)\u003c/p\u003e\n \u003cp\u003e185 (20.9)\u003c/p\u003e\n \u003cp\u003e190 (21.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e69 (27.2)\u003c/p\u003e\n \u003cp\u003e27 (10.6)\u003c/p\u003e\n \u003cp\u003e33 (13.0)\u003c/p\u003e\n \u003cp\u003e60 (23.6)\u003c/p\u003e\n \u003cp\u003e65 (25.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.375%\" valign=\"top\"\u003e\n \u003cp\u003e0.151\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"28.431372549019606%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.58823529411765%\" valign=\"top\"\u003e\n \u003cp\u003e3.0 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.0 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.764705882352942%\" valign=\"top\"\u003e\n \u003cp\u003e0.294\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.3125%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTherapeutic massage\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"22.65625%\" valign=\"top\"\u003e\n \u003cp\u003eNot interested at all (1)\u003c/p\u003e\n \u003cp\u003eNot very interested (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eInterested (4)\u003c/p\u003e\n \u003cp\u003eVery interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.40625%\" valign=\"top\"\u003e\n \u003cp\u003e196 (16.8)\u003c/p\u003e\n \u003cp\u003e80 (6.9)\u003c/p\u003e\n \u003cp\u003e157 (13.5)\u003c/p\u003e\n \u003cp\u003e339 (29.1)\u003c/p\u003e\n \u003cp\u003e394 (33.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e165 (18.4)\u003c/p\u003e\n \u003cp\u003e67 (7.5)\u003c/p\u003e\n \u003cp\u003e131 (14.6)\u003c/p\u003e\n \u003cp\u003e246 (27.4)\u003c/p\u003e\n \u003cp\u003e288 (32.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e31 (11.5)\u003c/p\u003e\n \u003cp\u003e13 (4.8)\u003c/p\u003e\n \u003cp\u003e26 (9.7)\u003c/p\u003e\n \u003cp\u003e93 (34.6)\u003c/p\u003e\n \u003cp\u003e106 (39.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.375%\" valign=\"top\"\u003e\n \u003cp\u003e0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"28.431372549019606%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.58823529411765%\" valign=\"top\"\u003e\n \u003cp\u003e3.6 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.5 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.9 (1.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.764705882352942%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.3125%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMeditation therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"22.65625%\" valign=\"top\"\u003e\n \u003cp\u003eNot interested at all (1)\u003c/p\u003e\n \u003cp\u003eNot very interested (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eInterested (4)\u003c/p\u003e\n \u003cp\u003eVery interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.40625%\" valign=\"top\"\u003e\n \u003cp\u003e243 (21.5)\u003c/p\u003e\n \u003cp\u003e131 (11.6)\u003c/p\u003e\n \u003cp\u003e224 (19.8)\u003c/p\u003e\n \u003cp\u003e284 (25.1)\u003c/p\u003e\n \u003cp\u003e248 (22.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e203 (23.3)\u003c/p\u003e\n \u003cp\u003e109 (12.5)\u003c/p\u003e\n \u003cp\u003e185 (21.2)\u003c/p\u003e\n \u003cp\u003e204 (23.4)\u003c/p\u003e\n \u003cp\u003e172 (19.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e40 (15.6)\u003c/p\u003e\n \u003cp\u003e22 (8.6)\u003c/p\u003e\n \u003cp\u003e39 (15.2)\u003c/p\u003e\n \u003cp\u003e80 (31.1)\u003c/p\u003e\n \u003cp\u003e76 (29.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.375%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"28.431372549019606%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.58823529411765%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.0 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.5 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.764705882352942%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.3125%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMusic therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"22.65625%\" valign=\"top\"\u003e\n \u003cp\u003eNot interested at all (1)\u003c/p\u003e\n \u003cp\u003eNot very interested (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eInterested (4)\u003c/p\u003e\n \u003cp\u003eVery interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.40625%\" valign=\"top\"\u003e\n \u003cp\u003e252 (22.7)\u003c/p\u003e\n \u003cp\u003e150 (13.5)\u003c/p\u003e\n \u003cp\u003e259 (23.4)\u003c/p\u003e\n \u003cp\u003e252 (22.7)\u003c/p\u003e\n \u003cp\u003e196 (17.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e218 (25.4)\u003c/p\u003e\n \u003cp\u003e130 (15.2)\u003c/p\u003e\n \u003cp\u003e203 (23.7)\u003c/p\u003e\n \u003cp\u003e181 (21.1)\u003c/p\u003e\n \u003cp\u003e126 (14.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e34 (13.6)\u003c/p\u003e\n \u003cp\u003e20 (8.0)\u003c/p\u003e\n \u003cp\u003e56 (22.3)\u003c/p\u003e\n \u003cp\u003e71 (28.3)\u003c/p\u003e\n \u003cp\u003e70 (27.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.375%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"28.431372549019606%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.58823529411765%\" valign=\"top\"\u003e\n \u003cp\u003e3.0 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e2.8 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.5 (1.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.764705882352942%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"20.3125%\" rowspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eYoga therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"22.65625%\" valign=\"top\"\u003e\n \u003cp\u003eNot interested at all (1)\u003c/p\u003e\n \u003cp\u003eNot very interested (2)\u003c/p\u003e\n \u003cp\u003eNeutral (3)\u003c/p\u003e\n \u003cp\u003eInterested (4)\u003c/p\u003e\n \u003cp\u003eVery interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.40625%\" valign=\"top\"\u003e\n \u003cp\u003e250 (22.2)\u003c/p\u003e\n \u003cp\u003e111 (9.8)\u003c/p\u003e\n \u003cp\u003e210 (18.6)\u003c/p\u003e\n \u003cp\u003e294 (26.1)\u003c/p\u003e\n \u003cp\u003e263 (23.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e205 (23.4)\u003c/p\u003e\n \u003cp\u003e94 (10.7)\u003c/p\u003e\n \u003cp\u003e178 (20.3)\u003c/p\u003e\n \u003cp\u003e213 (24.3)\u003c/p\u003e\n \u003cp\u003e186 (21.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e45 (17.9)\u003c/p\u003e\n \u003cp\u003e17 (6.8)\u003c/p\u003e\n \u003cp\u003e32 (12.7)\u003c/p\u003e\n \u003cp\u003e81 (32.0)\u003c/p\u003e\n \u003cp\u003e77 (30.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.375%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"28.431372549019606%\" valign=\"top\"\u003e\n \u003cp\u003eMean (SD)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.58823529411765%\" valign=\"top\"\u003e\n \u003cp\u003e3.2 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.1 (1.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"19.607843137254903%\" valign=\"top\"\u003e\n \u003cp\u003e3.5 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"11.764705882352942%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eAbbreviation: SD, standard deviation.\u003c/p\u003e\n\u003cp\u003eNote: Percentages may not be 100 due to rounding.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003eInterest was assessed by asking participants how interested they would be in these integrative medicine modalities if offered at the center.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u003c/sup\u003e \u003cem\u003ep\u003c/em\u003e-values were calculated using Student\u0026rsquo;s t tests for continuous data and Chi-square tests for categorical data.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 5.\u003c/strong\u003e Symptoms as facilitators for interest in using any integrative medicine modality among breast cancer patients, overall and by race\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"768\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eSymptoms as facilitators\u003c/strong\u003e\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal (N=1,213),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003eN (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eWhite (n=928),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBlack (n=285),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eHot flashes\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e410 (36.9)\u003c/p\u003e\n \u003cp\u003e199 (17.9)\u003c/p\u003e\n \u003cp\u003e503 (45.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e330 (38.1)\u003c/p\u003e\n \u003cp\u003e154 (17.8)\u003c/p\u003e\n \u003cp\u003e382 (44.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e80 (32.5)\u003c/p\u003e\n \u003cp\u003e45 (18.3)\u003c/p\u003e\n \u003cp\u003e121 (49.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.254\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eChemotherapy-induced neuropathy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e453 (41.4)\u003c/p\u003e\n \u003cp\u003e213 (19.5)\u003c/p\u003e\n \u003cp\u003e429 (39.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e354 (41.9)\u003c/p\u003e\n \u003cp\u003e170 (20.1)\u003c/p\u003e\n \u003cp\u003e321 (38.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e99 (39.6)\u003c/p\u003e\n \u003cp\u003e43 (17.2)\u003c/p\u003e\n \u003cp\u003e108 (43.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.297\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eNausea\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e487 (45.3)\u003c/p\u003e\n \u003cp\u003e259 (24.1)\u003c/p\u003e\n \u003cp\u003e329 (30.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e375 (45.0)\u003c/p\u003e\n \u003cp\u003e207 (24.8)\u003c/p\u003e\n \u003cp\u003e252 (30.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e112 (46.5)\u003c/p\u003e\n \u003cp\u003e52 (21.6)\u003c/p\u003e\n \u003cp\u003e77 (32.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.579\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eJoint pain\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e223 (19.4)\u003c/p\u003e\n \u003cp\u003e150 (13.1)\u003c/p\u003e\n \u003cp\u003e774 (67.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e175 (20.0)\u003c/p\u003e\n \u003cp\u003e121 (13.8)\u003c/p\u003e\n \u003cp\u003e580 (66.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e48 (17.7)\u003c/p\u003e\n \u003cp\u003e29 (10.7)\u003c/p\u003e\n \u003cp\u003e194 (71.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.227\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBack or other pain\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e221 (19.5)\u003c/p\u003e\n \u003cp\u003e152 (13.4)\u003c/p\u003e\n \u003cp\u003e762 (67.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e169 (19.5)\u003c/p\u003e\n \u003cp\u003e126 (14.6)\u003c/p\u003e\n \u003cp\u003e571 (65.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e52 (19.3)\u003c/p\u003e\n \u003cp\u003e26 (9.7)\u003c/p\u003e\n \u003cp\u003e191 (71.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.108\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eDepression/mood change\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e319 (28.8)\u003c/p\u003e\n \u003cp\u003e213 (19.2)\u003c/p\u003e\n \u003cp\u003e577 (52.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e238 (27.7)\u003c/p\u003e\n \u003cp\u003e170 (19.8)\u003c/p\u003e\n \u003cp\u003e451 (52.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e81 (32.4)\u003c/p\u003e\n \u003cp\u003e43 (17.2)\u003c/p\u003e\n \u003cp\u003e126 (50.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.313\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eFatigue/tiredness\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e245 (21.6)\u003c/p\u003e\n \u003cp\u003e164 (14.5)\u003c/p\u003e\n \u003cp\u003e726 (64.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e184 (21.2)\u003c/p\u003e\n \u003cp\u003e129 (14.8)\u003c/p\u003e\n \u003cp\u003e557 (64.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e61 (23.0)\u003c/p\u003e\n \u003cp\u003e35 (13.2)\u003c/p\u003e\n \u003cp\u003e169 (63.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.705\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.3728813559322%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAnxiety/stress reduction\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested (1,2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4,5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.166883963494133%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e248 (22.3)\u003c/p\u003e\n \u003cp\u003e167 (15.0)\u003c/p\u003e\n \u003cp\u003e699 (62.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.427640156453716%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e192 (22.3)\u003c/p\u003e\n \u003cp\u003e125 (14.5)\u003c/p\u003e\n \u003cp\u003e544 (63.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.645371577574968%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e56 (22.1)\u003c/p\u003e\n \u003cp\u003e42 (16.6)\u003c/p\u003e\n \u003cp\u003e155 (61.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.38722294654498%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.711\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eNote: Percentages may not be 100 due to rounding.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003eSymptoms as facilitators were assessed by asking participants how interested they would be in any integrative medicine modality if specifically treated the symptoms above.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u0026nbsp;\u003c/sup\u003e\u003cem\u003ep\u003c/em\u003e-values were calculated using Chi-square tests.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 6.\u003c/strong\u003e Facilitators for interest in using integrative medicine modalities among breast cancer patients, overall and by race\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"900\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"14.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eType of service\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"36.333333333333336%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eFacilitator\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal (N=1,213),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003eN (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eWhite (n=928),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBlack (n=285),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003csup\u003ea\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"14.666666666666666%\" rowspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAcupuncture\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"36.333333333333336%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eRecommendation from your doctor or nurse\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e206 (18.1)\u003c/p\u003e\n \u003cp\u003e101 (8.9)\u003c/p\u003e\n \u003cp\u003e186 (16.3)\u003c/p\u003e\n \u003cp\u003e320 (28.1)\u003c/p\u003e\n \u003cp\u003e328 (28.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e141 (16.0)\u003c/p\u003e\n \u003cp\u003e79 (9.0)\u003c/p\u003e\n \u003cp\u003e152 (17.2)\u003c/p\u003e\n \u003cp\u003e252 (28.6)\u003c/p\u003e\n \u003cp\u003e258 (29.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e65 (25.1)\u003c/p\u003e\n \u003cp\u003e22 (8.5)\u003c/p\u003e\n \u003cp\u003e34 (13.1)\u003c/p\u003e\n \u003cp\u003e68 (26.3)\u003c/p\u003e\n \u003cp\u003e70 (27.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.017\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCost not being a barrier\u003c/strong\u003e\u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e201 (18.0)\u003c/p\u003e\n \u003cp\u003e96 (8.6)\u003c/p\u003e\n \u003cp\u003e182 (16.3)\u003c/p\u003e\n \u003cp\u003e261 (23.3)\u003c/p\u003e\n \u003cp\u003e379 (33.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e141 (16.3)\u003c/p\u003e\n \u003cp\u003e74 (8.6)\u003c/p\u003e\n \u003cp\u003e149 (17.3)\u003c/p\u003e\n \u003cp\u003e201 (23.3)\u003c/p\u003e\n \u003cp\u003e299 (34.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e60 (23.5)\u003c/p\u003e\n \u003cp\u003e22 (8.6)\u003c/p\u003e\n \u003cp\u003e33 (12.9)\u003c/p\u003e\n \u003cp\u003e60 (23.5)\u003c/p\u003e\n \u003cp\u003e80 (31.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.073\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBeing covered by health insurance\u003c/strong\u003e\u003csup\u003ed\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e207 (18.4)\u003c/p\u003e\n \u003cp\u003e90 (8.0)\u003c/p\u003e\n \u003cp\u003e160 (14.2)\u003c/p\u003e\n \u003cp\u003e267 (23.8)\u003c/p\u003e\n \u003cp\u003e400 (35.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e145 (16.7)\u003c/p\u003e\n \u003cp\u003e68 (7.8)\u003c/p\u003e\n \u003cp\u003e130 (15.0)\u003c/p\u003e\n \u003cp\u003e207 (23.9)\u003c/p\u003e\n \u003cp\u003e318 (36.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e62 (24.2)\u003c/p\u003e\n \u003cp\u003e22 (8.6)\u003c/p\u003e\n \u003cp\u003e30 (11.7)\u003c/p\u003e\n \u003cp\u003e60 (23.4)\u003c/p\u003e\n \u003cp\u003e82 (32.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.065\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003ePrice willing to pay out of pocket for a session\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u0026nbsp;\u003c/strong\u003e$0\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $1-$19\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $20-$39\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $40-$59\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $60-$79\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $80-$99\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $100+\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e433 (40.1)\u003c/p\u003e\n \u003cp\u003e152 (14.1)\u003c/p\u003e\n \u003cp\u003e216 (20.0)\u003c/p\u003e\n \u003cp\u003e162 (15.0)\u003c/p\u003e\n \u003cp\u003e52 (4.8)\u003c/p\u003e\n \u003cp\u003e36 (3.3)\u003c/p\u003e\n \u003cp\u003e30 (2.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e303 (36.4)\u003c/p\u003e\n \u003cp\u003e116 (13.9)\u003c/p\u003e\n \u003cp\u003e183 (22.0)\u003c/p\u003e\n \u003cp\u003e131 (15.8)\u003c/p\u003e\n \u003cp\u003e43 (5.2)\u003c/p\u003e\n \u003cp\u003e33 (4.0)\u003c/p\u003e\n \u003cp\u003e23 (2.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e130 (52.2)\u003c/p\u003e\n \u003cp\u003e36 (14.5)\u003c/p\u003e\n \u003cp\u003e33 (13.3)\u003c/p\u003e\n \u003cp\u003e31 (12.5)\u003c/p\u003e\n \u003cp\u003e9 (3.6)\u003c/p\u003e\n \u003cp\u003e3 (1.2)\u003c/p\u003e\n \u003cp\u003e7 (2.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"14.666666666666666%\" rowspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTherapeutic massage\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"36.333333333333336%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eRecommendation from your doctor or nurse\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e106 (9.1)\u003c/p\u003e\n \u003cp\u003e46 (3.9)\u003c/p\u003e\n \u003cp\u003e147 (12.6)\u003c/p\u003e\n \u003cp\u003e414 (35.4)\u003c/p\u003e\n \u003cp\u003e458 (39.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e80 (8.9)\u003c/p\u003e\n \u003cp\u003e34 (3.8)\u003c/p\u003e\n \u003cp\u003e122 (13.6)\u003c/p\u003e\n \u003cp\u003e317 (35.3)\u003c/p\u003e\n \u003cp\u003e345 (38.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e26 (9.5)\u003c/p\u003e\n \u003cp\u003e12 (4.4)\u003c/p\u003e\n \u003cp\u003e25 (9.2)\u003c/p\u003e\n \u003cp\u003e97 (35.5)\u003c/p\u003e\n \u003cp\u003e113 (41.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.402\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCost not being a barrier\u003c/strong\u003e\u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e104 (9.1)\u003c/p\u003e\n \u003cp\u003e50 (4.4)\u003c/p\u003e\n \u003cp\u003e141 (12.3)\u003c/p\u003e\n \u003cp\u003e337 (29.5)\u003c/p\u003e\n \u003cp\u003e512 (44.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e79 (9.0)\u003c/p\u003e\n \u003cp\u003e41 (4.7)\u003c/p\u003e\n \u003cp\u003e116 (13.2)\u003c/p\u003e\n \u003cp\u003e250 (28.5)\u003c/p\u003e\n \u003cp\u003e391 (44.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e25 (9.4)\u003c/p\u003e\n \u003cp\u003e9 (3.4)\u003c/p\u003e\n \u003cp\u003e25 (9.4)\u003c/p\u003e\n \u003cp\u003e87 (32.6)\u003c/p\u003e\n \u003cp\u003e121 (45.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.344\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBeing covered by health insurance\u003c/strong\u003e\u003csup\u003ed\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e103 (8.9)\u003c/p\u003e\n \u003cp\u003e49 (4.3)\u003c/p\u003e\n \u003cp\u003e123 (10.7)\u003c/p\u003e\n \u003cp\u003e346 (30.0)\u003c/p\u003e\n \u003cp\u003e531 (46.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e79 (9.0)\u003c/p\u003e\n \u003cp\u003e38 (4.3)\u003c/p\u003e\n \u003cp\u003e101 (11.5)\u003c/p\u003e\n \u003cp\u003e254 (28.9)\u003c/p\u003e\n \u003cp\u003e406 (46.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e24 (8.8)\u003c/p\u003e\n \u003cp\u003e11 (4.0)\u003c/p\u003e\n \u003cp\u003e22 (8.0)\u003c/p\u003e\n \u003cp\u003e92 (33.6)\u003c/p\u003e\n \u003cp\u003e125 (45.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.414\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003ePrice willing to pay out of pocket for a session\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u0026nbsp;\u003c/strong\u003e$0\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $1-$19\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $20-$39\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $40-$59\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $60-$79\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $80-$99\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $100+\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e268 (24.2)\u003c/p\u003e\n \u003cp\u003e179 (16.2)\u003c/p\u003e\n \u003cp\u003e267 (24.1)\u003c/p\u003e\n \u003cp\u003e198 (17.9)\u003c/p\u003e\n \u003cp\u003e103 (9.3)\u003c/p\u003e\n \u003cp\u003e52 (4.7)\u003c/p\u003e\n \u003cp\u003e41 (3.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e178 (21.1)\u003c/p\u003e\n \u003cp\u003e128 (15.2)\u003c/p\u003e\n \u003cp\u003e219 (25.9)\u003c/p\u003e\n \u003cp\u003e159 (18.8)\u003c/p\u003e\n \u003cp\u003e90 (10.7)\u003c/p\u003e\n \u003cp\u003e41 (4.9)\u003c/p\u003e\n \u003cp\u003e30 (3.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e90 (34.2)\u003c/p\u003e\n \u003cp\u003e51 (19.4)\u003c/p\u003e\n \u003cp\u003e48 (18.3)\u003c/p\u003e\n \u003cp\u003e39 (14.8)\u003c/p\u003e\n \u003cp\u003e13 (4.9)\u003c/p\u003e\n \u003cp\u003e11 (4.2)\u003c/p\u003e\n \u003cp\u003e11 (4.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"14.666666666666666%\" rowspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMeditation therapy\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"36.333333333333336%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eRecommendation from your doctor or nurse\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e162 (14.2)\u003c/p\u003e\n \u003cp\u003e97 (8.5)\u003c/p\u003e\n \u003cp\u003e220 (19.3)\u003c/p\u003e\n \u003cp\u003e354 (31.1)\u003c/p\u003e\n \u003cp\u003e307 (26.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e123 (14.0)\u003c/p\u003e\n \u003cp\u003e81 (9.2)\u003c/p\u003e\n \u003cp\u003e187 (21.3)\u003c/p\u003e\n \u003cp\u003e271 (30.8)\u003c/p\u003e\n \u003cp\u003e218 (24.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e39 (15.0)\u003c/p\u003e\n \u003cp\u003e16 (6.2)\u003c/p\u003e\n \u003cp\u003e33 (12.7)\u003c/p\u003e\n \u003cp\u003e83 (31.9)\u003c/p\u003e\n \u003cp\u003e89 (34.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.002\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCost not being a barrier\u003c/strong\u003e\u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e163 (14.7)\u003c/p\u003e\n \u003cp\u003e86 (7.7)\u003c/p\u003e\n \u003cp\u003e212 (19.1)\u003c/p\u003e\n \u003cp\u003e298 (26.8)\u003c/p\u003e\n \u003cp\u003e353 (31.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e125 (14.6)\u003c/p\u003e\n \u003cp\u003e71 (8.3)\u003c/p\u003e\n \u003cp\u003e180 (21.1)\u003c/p\u003e\n \u003cp\u003e226 (26.4)\u003c/p\u003e\n \u003cp\u003e253 (29.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e38 (14.8)\u003c/p\u003e\n \u003cp\u003e15 (5.8)\u003c/p\u003e\n \u003cp\u003e32 (12.5)\u003c/p\u003e\n \u003cp\u003e72 (28.0)\u003c/p\u003e\n \u003cp\u003e100 (38.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.005\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBeing covered by health insurance\u003c/strong\u003e\u003csup\u003ed\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e161 (14.3)\u003c/p\u003e\n \u003cp\u003e86 (7.7)\u003c/p\u003e\n \u003cp\u003e202 (18.0)\u003c/p\u003e\n \u003cp\u003e305 (27.2)\u003c/p\u003e\n \u003cp\u003e369 (32.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e124 (14.3)\u003c/p\u003e\n \u003cp\u003e73 (8.4)\u003c/p\u003e\n \u003cp\u003e175 (20.2)\u003c/p\u003e\n \u003cp\u003e228 (26.4)\u003c/p\u003e\n \u003cp\u003e265 (30.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e37 (14.3)\u003c/p\u003e\n \u003cp\u003e13 (5.0)\u003c/p\u003e\n \u003cp\u003e27 (10.5)\u003c/p\u003e\n \u003cp\u003e77 (29.8)\u003c/p\u003e\n \u003cp\u003e104 (40.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003ePrice willing to pay out of pocket for a session\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u0026nbsp;\u003c/strong\u003e$0\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $1-$19\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $20-$39\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $40-$59\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $60-$79\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $80-$99\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $100+\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e446 (41.8)\u003c/p\u003e\n \u003cp\u003e224 (21.0)\u003c/p\u003e\n \u003cp\u003e222 (20.8)\u003c/p\u003e\n \u003cp\u003e116 (10.9)\u003c/p\u003e\n \u003cp\u003e25 (2.3)\u003c/p\u003e\n \u003cp\u003e19 (1.8)\u003c/p\u003e\n \u003cp\u003e15 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e327 (40.1)\u003c/p\u003e\n \u003cp\u003e178 (21.8)\u003c/p\u003e\n \u003cp\u003e177 (21.7)\u003c/p\u003e\n \u003cp\u003e92 (11.3)\u003c/p\u003e\n \u003cp\u003e19 (2.3)\u003c/p\u003e\n \u003cp\u003e14 (1.7)\u003c/p\u003e\n \u003cp\u003e8 (1.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e119 (47.2)\u003c/p\u003e\n \u003cp\u003e46 (18.3)\u003c/p\u003e\n \u003cp\u003e45 (17.9)\u003c/p\u003e\n \u003cp\u003e24 (9.5)\u003c/p\u003e\n \u003cp\u003e6 (2.4)\u003c/p\u003e\n \u003cp\u003e5 (2.0)\u003c/p\u003e\n \u003cp\u003e7 (2.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.128\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"14.666666666666666%\" rowspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMusic therapy\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"36.333333333333336%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eRecommendation from your doctor or nurse\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e177 (15.9)\u003c/p\u003e\n \u003cp\u003e117 (10.5)\u003c/p\u003e\n \u003cp\u003e251 (22.6)\u003c/p\u003e\n \u003cp\u003e314 (28.2)\u003c/p\u003e\n \u003cp\u003e254 (22.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e139 (16.2)\u003c/p\u003e\n \u003cp\u003e103 (12.0)\u003c/p\u003e\n \u003cp\u003e206 (24.0)\u003c/p\u003e\n \u003cp\u003e233 (27.1)\u003c/p\u003e\n \u003cp\u003e178 (20.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e38 (15.0)\u003c/p\u003e\n \u003cp\u003e14 (5.5)\u003c/p\u003e\n \u003cp\u003e45 (17.7)\u003c/p\u003e\n \u003cp\u003e81 (31.9)\u003c/p\u003e\n \u003cp\u003e76 (29.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCost not being a barrier\u003c/strong\u003e\u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e177 (16.2)\u003c/p\u003e\n \u003cp\u003e109 (10.0)\u003c/p\u003e\n \u003cp\u003e241 (22.1)\u003c/p\u003e\n \u003cp\u003e264 (24.2)\u003c/p\u003e\n \u003cp\u003e300 (27.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e143 (17.0)\u003c/p\u003e\n \u003cp\u003e98 (11.7)\u003c/p\u003e\n \u003cp\u003e198 (23.5)\u003c/p\u003e\n \u003cp\u003e196 (23.3)\u003c/p\u003e\n \u003cp\u003e206 (24.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e34 (13.6)\u003c/p\u003e\n \u003cp\u003e11 (4.4)\u003c/p\u003e\n \u003cp\u003e43 (17.2)\u003c/p\u003e\n \u003cp\u003e68 (27.2)\u003c/p\u003e\n \u003cp\u003e94 (37.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBeing covered by health insurance\u003c/strong\u003e\u003csup\u003ed\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e176 (16.1)\u003c/p\u003e\n \u003cp\u003e104 (9.5)\u003c/p\u003e\n \u003cp\u003e234 (21.5)\u003c/p\u003e\n \u003cp\u003e281 (25.8)\u003c/p\u003e\n \u003cp\u003e296 (27.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e143 (17.0)\u003c/p\u003e\n \u003cp\u003e94 (11.2)\u003c/p\u003e\n \u003cp\u003e194 (23.1)\u003c/p\u003e\n \u003cp\u003e207 (24.6)\u003c/p\u003e\n \u003cp\u003e202 (24.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e33 (13.2)\u003c/p\u003e\n \u003cp\u003e10 (4.0)\u003c/p\u003e\n \u003cp\u003e40 (15.9)\u003c/p\u003e\n \u003cp\u003e74 (29.5)\u003c/p\u003e\n \u003cp\u003e94 (37.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003ePrice willing to pay out of pocket for a session\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; \u0026nbsp;$0\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $1-$19\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $20-$39\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $40-$59\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $60-$79\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $80-$99\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $100+\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e531 (50.7)\u003c/p\u003e\n \u003cp\u003e198 (18.9)\u003c/p\u003e\n \u003cp\u003e176 (16.8)\u003c/p\u003e\n \u003cp\u003e96 (9.2)\u003c/p\u003e\n \u003cp\u003e23 (2.2)\u003c/p\u003e\n \u003cp\u003e9 (0.9)\u003c/p\u003e\n \u003cp\u003e15 (1.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e403 (50.3)\u003c/p\u003e\n \u003cp\u003e152 (19.0)\u003c/p\u003e\n \u003cp\u003e140 (17.5)\u003c/p\u003e\n \u003cp\u003e74 (9.2)\u003c/p\u003e\n \u003cp\u003e17 (2.1)\u003c/p\u003e\n \u003cp\u003e7 (0.9)\u003c/p\u003e\n \u003cp\u003e9 (1.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e128 (52.0)\u003c/p\u003e\n \u003cp\u003e46 (18.7)\u003c/p\u003e\n \u003cp\u003e36 (14.6)\u003c/p\u003e\n \u003cp\u003e22 (8.9)\u003c/p\u003e\n \u003cp\u003e6 (2.4)\u003c/p\u003e\n \u003cp\u003e2 (0.8)\u003c/p\u003e\n \u003cp\u003e6 (2.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.756\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"14.666666666666666%\" rowspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eYoga therapy\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"36.333333333333336%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eRecommendation from your doctor or nurse\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e176 (15.6)\u003c/p\u003e\n \u003cp\u003e78 (6.9)\u003c/p\u003e\n \u003cp\u003e201 (17.8)\u003c/p\u003e\n \u003cp\u003e373 (33.1)\u003c/p\u003e\n \u003cp\u003e300 (26.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e132 (15.1)\u003c/p\u003e\n \u003cp\u003e68 (7.8)\u003c/p\u003e\n \u003cp\u003e170 (19.5)\u003c/p\u003e\n \u003cp\u003e281 (32.2)\u003c/p\u003e\n \u003cp\u003e222 (25.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.333333333333334%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e44 (17.3)\u003c/p\u003e\n \u003cp\u003e10 (3.9)\u003c/p\u003e\n \u003cp\u003e31 (12.2)\u003c/p\u003e\n \u003cp\u003e92 (36.1)\u003c/p\u003e\n \u003cp\u003e78 (30.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"8.666666666666666%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.009\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCost not being a barrier\u003c/strong\u003e\u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e163 (14.9)\u003c/p\u003e\n \u003cp\u003e80 (7.3)\u003c/p\u003e\n \u003cp\u003e197 (18.0)\u003c/p\u003e\n \u003cp\u003e296 (27.0)\u003c/p\u003e\n \u003cp\u003e361 (32.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e123 (14.5)\u003c/p\u003e\n \u003cp\u003e69 (8.1)\u003c/p\u003e\n \u003cp\u003e169 (19.9)\u003c/p\u003e\n \u003cp\u003e221 (26.0)\u003c/p\u003e\n \u003cp\u003e268 (31.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e40 (16.2)\u003c/p\u003e\n \u003cp\u003e11 (4.5)\u003c/p\u003e\n \u003cp\u003e28 (11.3)\u003c/p\u003e\n \u003cp\u003e75 (30.4)\u003c/p\u003e\n \u003cp\u003e93 (37.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.004\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBeing covered by health insurance\u003c/strong\u003e\u003csup\u003ed\u003c/sup\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not interested at all (1)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Not very interested (2)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Neutral (3)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Interested (4)\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Very interested (5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e175 (15.7)\u003c/p\u003e\n \u003cp\u003e71 (6.4)\u003c/p\u003e\n \u003cp\u003e186 (16.7)\u003c/p\u003e\n \u003cp\u003e302 (27.0)\u003c/p\u003e\n \u003cp\u003e383 (34.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e133 (15.5)\u003c/p\u003e\n \u003cp\u003e62 (7.2)\u003c/p\u003e\n \u003cp\u003e160 (18.6)\u003c/p\u003e\n \u003cp\u003e222 (25.8)\u003c/p\u003e\n \u003cp\u003e283 (32.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e42 (16.3)\u003c/p\u003e\n \u003cp\u003e9 (3.5)\u003c/p\u003e\n \u003cp\u003e26 (10.1)\u003c/p\u003e\n \u003cp\u003e80 (31.1)\u003c/p\u003e\n \u003cp\u003e100 (38.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.002\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"42.578125%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003ePrice willing to pay out of pocket for a session\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp;\u0026nbsp;\u003c/strong\u003e$0\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $1-$19\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $20-$39\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $40-$59\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $60-$79\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $80-$99\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; $100+\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"16.015625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e404 (37.7)\u003c/p\u003e\n \u003cp\u003e258 (24.1)\u003c/p\u003e\n \u003cp\u003e247 (23.1)\u003c/p\u003e\n \u003cp\u003e101 (9.4)\u003c/p\u003e\n \u003cp\u003e31 (2.9)\u003c/p\u003e\n \u003cp\u003e12 (1.1)\u003c/p\u003e\n \u003cp\u003e18 (1.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e295 (35.8)\u003c/p\u003e\n \u003cp\u003e209 (25.4)\u003c/p\u003e\n \u003cp\u003e196 (23.8)\u003c/p\u003e\n \u003cp\u003e77 (9.3)\u003c/p\u003e\n \u003cp\u003e24 (2.9)\u003c/p\u003e\n \u003cp\u003e10 (1.2)\u003c/p\u003e\n \u003cp\u003e13 (1.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e109 (44.1)\u003c/p\u003e\n \u003cp\u003e49 (19.8)\u003c/p\u003e\n \u003cp\u003e51 (20.7)\u003c/p\u003e\n \u003cp\u003e24 (9.7)\u003c/p\u003e\n \u003cp\u003e7 (2.8)\u003c/p\u003e\n \u003cp\u003e2 (0.8)\u003c/p\u003e\n \u003cp\u003e5 (2.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"10.15625%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.298\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eNote: Percentages may not be 100 due to rounding.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003e\u003cem\u003ep\u003c/em\u003e-values were calculated using Chi-square tests.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u003c/sup\u003e Recommendation from your doctor or nurse was assessed by asking participants how interested they would be to have any integrative medicine modality if their doctor or nurse recommended it.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ec\u0026nbsp;\u003c/sup\u003eCost not being a barrier was assessed by asking participants how interested they would be to have any integrative medicine modality if cost was not a barrier.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ed\u0026nbsp;\u003c/sup\u003eBeing covered by health insurance was assessed by asking participants how interested they would be to have any integrative medicine modality if their health insurance paid for it.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 7.\u003c/strong\u003e Self-reported use of integrative medicine modalities among breast cancer patients, overall and by race\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"25.039123630672925%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eType of service\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal (N=1,213),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003eN (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.5962441314554%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eWhite (n=928),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBlack (n=285),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.363067292644757%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003csup\u003ea\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"25.039123630672925%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eAcupuncture\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e897 (73.9)\u003c/p\u003e\n \u003cp\u003e316 (26.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.5962441314554%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e654 (70.5)\u003c/p\u003e\n \u003cp\u003e274 (29.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e243 (85.3)\u003c/p\u003e\n \u003cp\u003e42 (14.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.363067292644757%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"25.039123630672925%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTherapeutic massage\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e708 (58.4)\u003c/p\u003e\n \u003cp\u003e505 (41.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.5962441314554%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e530 (57.1)\u003c/p\u003e\n \u003cp\u003e398 (42.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e178 (62.5)\u003c/p\u003e\n \u003cp\u003e107 (37.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.363067292644757%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.109\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"25.039123630672925%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMeditation therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e989 (81.5)\u003c/p\u003e\n \u003cp\u003e224 (18.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.5962441314554%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e754 (81.3)\u003c/p\u003e\n \u003cp\u003e174 (18.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e235 (82.5)\u003c/p\u003e\n \u003cp\u003e50 (17.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.363067292644757%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.646\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"25.039123630672925%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eMusic therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e1,120 (92.3)\u003c/p\u003e\n \u003cp\u003e93 (7.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.5962441314554%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e867 (93.4)\u003c/p\u003e\n \u003cp\u003e61 (6.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e253 (88.8)\u003c/p\u003e\n \u003cp\u003e32 (11.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.363067292644757%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.009\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"25.039123630672925%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eYoga therapy\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e983 (81.0)\u003c/p\u003e\n \u003cp\u003e230 (19.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"21.5962441314554%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e735 (79.2)\u003c/p\u003e\n \u003cp\u003e193 (20.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"20.50078247261346%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e248 (87.0)\u003c/p\u003e\n \u003cp\u003e37 (13.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"12.363067292644757%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.003\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eNote: Percentages may not be 100 due to rounding.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003e\u003cem\u003ep\u003c/em\u003e-values were calculated using Chi-square tests.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u0026nbsp;\u003c/sup\u003eParticipants were asked about these integrative medicine modalities they have used in the past.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTable 8.\u003c/strong\u003e Barriers to using any integrative medicine modality among breast cancer patients, overall and by race\u003c/p\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"792\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBarrier\u003c/strong\u003e\u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal (N=1,213),\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003eN (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eWhite (n=928)\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eBlack (n=285)\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u003cstrong\u003en (%)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003cstrong\u003e-value\u003c/strong\u003e\u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eCost/money\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e765 (63.1)\u003c/p\u003e\n \u003cp\u003e448 (36.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e637 (68.6)\u003c/p\u003e\n \u003cp\u003e291 (31.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e128 (44.9)\u003c/p\u003e\n \u003cp\u003e157 (55.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eLack of access to services\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e963 (79.4)\u003c/p\u003e\n \u003cp\u003e250 (20.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e748 (80.6)\u003c/p\u003e\n \u003cp\u003e180 (19.4)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e215 (75.4)\u003c/p\u003e\n \u003cp\u003e70 (24.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.059\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eLack of transportation to service-providing facilities\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e1,090 (89.9)\u003c/p\u003e\n \u003cp\u003e123 (10.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e842 (90.7)\u003c/p\u003e\n \u003cp\u003e86 (9.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e248 (87.0)\u003c/p\u003e\n \u003cp\u003e37 (13.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.069\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eLack of time\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e859 (70.8)\u003c/p\u003e\n \u003cp\u003e354 (29.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e629 (67.8)\u003c/p\u003e\n \u003cp\u003e299 (32.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e230 (80.7)\u003c/p\u003e\n \u003cp\u003e55 (19.3)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eLack of interest\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e1,017 (83.8)\u003c/p\u003e\n \u003cp\u003e196 (16.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e768 (82.8)\u003c/p\u003e\n \u003cp\u003e160 (17.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e249 (87.4)\u003c/p\u003e\n \u003cp\u003e36 (12.6)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.064\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eUnaware of benefits of these services\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u0026nbsp;\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e889 (73.3)\u003c/p\u003e\n \u003cp\u003e324 (26.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e706 (76.1)\u003c/p\u003e\n \u003cp\u003e222 (23.9)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e183 (64.2)\u003c/p\u003e\n \u003cp\u003e102 (35.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e\u0026lt;0.001\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eLow confidence about the benefits on these services\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e1,102 (90.9)\u003c/p\u003e\n \u003cp\u003e111 (9.2)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e844 (91.0)\u003c/p\u003e\n \u003cp\u003e84 (9.1)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e258 (90.5)\u003c/p\u003e\n \u003cp\u003e27 (9.5)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.829\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd width=\"46.21212121212121%\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eLack of trusted information on these services\u003c/strong\u003e\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; No\u003c/p\u003e\n \u003cp\u003e\u0026nbsp; Yes\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.782828282828282%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e1,128 (93.0)\u003c/p\u003e\n \u003cp\u003e85 (7.0)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"15.151515151515152%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e865 (93.2)\u003c/p\u003e\n \u003cp\u003e63 (6.8)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"13.636363636363637%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e263 (92.3)\u003c/p\u003e\n \u003cp\u003e22 (7.7)\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd width=\"9.217171717171718%\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;\u003c/p\u003e\n \u003cp\u003e0.590\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eNote: Percentages may not be 100 due to rounding.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003csup\u003ea\u0026nbsp;\u003c/sup\u003eBarriers were assessed by asking participants what, in general, prevents them from using any integrative medicine modality.\u003c/p\u003e\n\u003cp\u003e\u003csup\u003eb\u0026nbsp;\u003c/sup\u003e\u003cem\u003ep\u003c/em\u003e-values were calculated using Chi-square tests.\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"breast-cancer-research-and-treatment","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"brea","sideBox":"Learn more about [Breast Cancer Research and Treatment](https://www.springer.com/journal/10549)","snPcode":"10549","submissionUrl":"https://submission.nature.com/new-submission/10549/3","title":"Breast Cancer Research and Treatment","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Integrative medicine, racial disparities, breast cancer, ChiMEC","lastPublishedDoi":"10.21203/rs.3.rs-3909360/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3909360/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003ePurpose\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIntegrative medicine (IM) has received ASCO endorsement for managing cancer treatment-related side effects. Little is known about racial differences in familiarity, interest, and use of IM among breast cancer patients.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eBreast cancer patients enrolled in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort were surveyed regarding familiarity, interest, and use of IM: acupuncture, massage, meditation, music therapy, and yoga. Familiarity and interest, measured by a 5-point Likert scale, was modeled using proportional odds. Use was self-reported, modeled using binary logistic regression.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResults\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eOf 1,300 respondents (71.4% White and 21.9% Black), Black patients were less likely than White patients to be familiar with acupuncture (aOR 0.60, 95% CI: 0.41-0.87). While there was no differences in interest in acupuncture between Black and White patients (aOR 1.12, 95% CI: 0.76-1.65), Black patients were more interested in massage (aOR 1.86, 95% CI: 1.25-2.77), meditation (aOR 2.03, 95% CI: 1.37-3.00), music therapy (aOR 2.68, 95% CI: 1.80-3.99) and yoga (aOR 2.10, 95% CI: 1.41-3.12). Black patients were less likely than White to have used acupuncture (aOR 0.49, 95% CI: 0.29-0.84); but there were no racial differences in use of massage (aOR 0.83, 95% CI: 0.53-1.30), meditation (aOR 0.82, 95% CI: 0.47-1.43), music therapy (aOR 1.65, 95% CI: 0.82-3.32) and yoga (aOR 0.67, 95% CI: 0.37-1.20).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eBlack patients expressed more interest in IM than their White counterparts; there were no racial differences in IM use, except lower acupuncture use among Black patients. A breast program focused on equity should provide access to these services for breast cancer patients.\u003c/p\u003e","manuscriptTitle":"Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-02-01 16:50:49","doi":"10.21203/rs.3.rs-3909360/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2024-03-06T09:42:16+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-03-06T09:38:48+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-02-20T12:58:21+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"f6c6113e-8daf-4497-8464-f7edddab5c92_SNPRID","date":"2024-02-09T11:39:45+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2024-02-08T22:09:02+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2024-01-30T05:31:06+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2024-01-30T05:31:06+00:00","index":"","fulltext":""},{"type":"submitted","content":"Breast Cancer Research and Treatment","date":"2024-01-29T18:50:19+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"breast-cancer-research-and-treatment","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"brea","sideBox":"Learn more about [Breast Cancer Research and Treatment](https://www.springer.com/journal/10549)","snPcode":"10549","submissionUrl":"https://submission.nature.com/new-submission/10549/3","title":"Breast Cancer Research and Treatment","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"8eb62174-4b26-42e1-adea-a1aaf2841a45","owner":[],"postedDate":"February 1st, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2024-04-24T15:46:07+00:00","versionOfRecord":[],"versionCreatedAt":"2024-02-01 16:50:49","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-3909360","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3909360","identity":"rs-3909360","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}